Sign in
  • S&P 500 7,659.44 −1.09%
  • Dow Jones 52,002.41 −0.34%
  • Nasdaq 26,713.03 +0.08%
  • VIX 19.99 +21.45%
  • 10-year Treasury 5.09% −0.01
  • Dollar index 121.40 −0.14%
  • WTI crude $101.91 +1.04%

Biotech calendar

Upcoming clinical trial readouts and FDA advisory committee meetings for drug and biotech companies, month by month, from ClinicalTrials.gov and the FDA, with the companies’ next earnings dates. Dates are the sponsors’ own estimates and often slip.

The next 12 months

1,008 phase 3 and 1,761 phase 2 industry trials have an estimated primary completion between Oct 21, 2026 and Oct 21, 2027, and the FDA has 1 advisory committee agenda item scheduled. Each month below lists the advisory committees and the phase 3 readouts; its own page has every phase 2 and phase 3 readout. Phase 1 and unphased studies (2,884) are left out.

The count beside each month is phase 3 readouts plus advisory committee items.

October 2026

FDA advisory committees

Phase 3 readouts: 28

Primary completionSponsorDrugConditionPhaseRecord
Oct 22, 2026AmgenDazodalibepSjögren's Syndrome (SS)Phase 3NCT06245408
Oct 22, 2026Roche HoldingOcrelizumabProgressive Multiple Sclerosis (PMS)Phase 3NCT03523858
Oct 23, 2026Qilu Pharmaceutical Co., Ltd.3-6mg QLM1016, 10-20 mg Aripiprazole oral solution filmSchizophreniaPhase 3NCT06799559
Oct 26, 2026Csl LtdRecombinant single-chain factor VIII (rVIII-SingleChain)Congenital Hemophilia APhase 3NCT06738485
Oct 26, 2026Galderma Group AG/ADRNemolizumabPrurigo NodularisPhase 3NCT04204616
Oct 26, 2026NovartisInclisiran sodium 300 mgCoronary Artery DiseasePhase 3NCT05360446
Oct 28, 2026AkesoCadonilimab (AK104), SugemalimabNSCLC (Non-small Cell Lung Cancer)Phase 3NCT06617416
Oct 28, 2026Albireo, an Ipsen CompanyOdevixibatBiliary AtresiaPhase 3NCT05426733
Oct 28, 2026Roche HoldingRO7204239, RisdiplamSpinal Muscular Atrophy (SMA)Phase 2/3NCT05115110
Oct 28, 2026Merck & Co.Belzutifan, PembrolizumabCarcinoma, Renal CellPhase 3NCT05239728
Oct 29, 2026Roche HoldingAfimkibartModerately to Severely Active Ulcerative ColitisPhase 3NCT06588855
Oct 29, 2026NovartisIanalumab, CorticosteroidsPrimary Immune Thrombocytopenia (ITP)Phase 3NCT05653349
Oct 30, 2026CSPC Pharmaceutical Group–Type 2 DiabetesPhase 3NCT07026968
Oct 30, 2026Kind Pharmaceuticals LLCAND017 capsules, ESAAnemia Due to Chronic Kidney DiseasePhase 3NCT07494409
Oct 30, 2026Laekna LimitedAfuresertibBreast CancerPhase 3NCT04851613
Oct 30, 2026Natureceuticals Sdn BhdNuvastatic 300Fatigue Related to Cancer Treatment, Breast CancerPhase 3NCT07669467
Oct 30, 2026PfizerEncorafenib, Binimetinib, PembrolizumabMelanomaPhase 3NCT04657991
Oct 30, 2026Vertex PharmaceuticalsVX-121/TEZ/D-IVACystic FibrosisPhase 3NCT05444257
Oct 31, 2026AstraZenecaCapivasertib, FulvestrantBreast CancerPhase 3NCT06635447
Oct 31, 2026Jiangsu Hengrui MedicineSHR6390Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast CancerPhase 3NCT04842617
Oct 31, 2026Longboard Pharmaceuticals, Inc.LP352Developmental and Epileptic EncephalopathyPhase 3NCT06719141
Oct 31, 2026Natureceuticals Sdn BhdNuvastatic 300Fatigue Related to Cancer Treatment, Colon CancerPhase 3NCT07669454
Oct 31, 2026Olema Pharmaceuticals, Inc.Palazestrant, Fulvestrant, Anastrozole and 2 moreBreast Cancer, Advanced Breast Cancer and 3 morePhase 3NCT06016738
Oct 31, 2026Sarepta TherapeuticsEteplirsenMuscular Dystrophy, DuchennePhase 3NCT03992430
Oct 31, 2026TG TherapeuticsUblituximabRelapsing Multiple SclerosisPhase 3NCT07211633
Oct 31, 2026Takeda Pharmaceutical CompanyTAK-788, Pemetrexed, Cisplatin and 1 moreAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 3NCT04129502
Oct 31, 2026Teva Pharmaceutical Industries Ltd.TEV-56248, Albuterol sulfateAsthmaPhase 3NCT06052267
Oct 31, 2026UCBStaccato alprazolamStereotypical Prolonged SeizuresPhase 3NCT05077904

53 phase 2 readouts too. All 81 phase 2 and 3 readouts in Oct 2026

November 2026

Phase 3 readouts: 72

Primary completionSponsorDrugConditionPhaseRecord
Nov 2026AbbVieUpadacitinib 15mg Dose, Dupilumab 300mg Dose, Upadacitinib 30mg DoseAtopic DermatitisPhase 3NCT06389136
Nov 2026Akesocadonilimab, pulocimab, paclitaxelGastric and Gastroesophageal Junction AdenocarcinomaPhase 3NCT06341335
Nov 2026CG Oncology, Inc.Cretostimogene Grenadenorepvec, n-dodecyl-B-D-maltosideNon Muscle Invasive Bladder Cancer, Urologic Cancer and 2 morePhase 3NCT06111235
Nov 2026CamurusCAM2029, Octreotide LAR, Lanreotide ATGGastro-enteropancreatic Neuroendocrine TumorPhase 3NCT05050942
Nov 2026Colgate-Palmolive CompanyColgate SNaP Total 10/10, 1.5 Taurate, Colgate Great Regular Flavor Toothpaste, Flat Trimmed Extra Clean TBPlaque, Dental, GingivitisPhase 3NCT07605338
Nov 2026DBV TechnologiesDBV712 250 mcgAllergy, Peanut AllergyPhase 3NCT07003919
Nov 2026Eli Lilly and CompanyTirzepatideType 1 Diabetes, Obesity and 1 morePhase 3NCT06962280
Nov 2026Eli Lilly and CompanyTirzepatideType 1 Diabetes, Obesity and 1 morePhase 3NCT06914895
Nov 2026Eli Lilly and CompanyRetatrutide, TirzepatideObesityPhase 3NCT06662383
Nov 2026Immunic AGIMU-838 tabletsMultiple Sclerosis, Relapsing-RemittingPhase 3NCT05201638
Nov 2026Immunic AGIMU-838 tabletsMultiple SclerosisPhase 3NCT05134441
Nov 2026Lynk Pharmaceuticals Co., LtdLNK01001Ankylosing SpondylitisPhase 3NCT07237568
Nov 2026Medicure IncPyridoxal PhosphatePyridox(am)Ine 5'-Phosphate Oxidase DeficiencyPhase 3NCT04706013
Nov 2026Nanjing Chia-tai Tianqing PharmaceuticalNTQ5082 capsules 200 mg, Eculizumab InjectionParoxysmal Nocturnal HemoglobinuriaPhase 3NCT07177859
Nov 2026NewAmsterdam Pharma Co N.V.ObicetrapibAtherosclerotic Cardiovascular DiseasePhase 3NCT05202509
Nov 2026Nuance HearingSpectacle Hearing AidHearing Loss MixedPhase 2/3NCT07282028
Nov 2026SandozCYB704, Ocrevus-EU, Ocrevus-USRelapsing Multiple SclerosisPhase 3NCT06847724
Nov 2026Sichuan Baili Pharmaceutical Co., Ltd.BL-B01D1, capecitabine, gemcitabine and 1 moreNasopharyngeal CarcinomaPhase 3NCT06118333
Nov 2026Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SKB264, PembrolizumabNon-Small Cell Lung CancerPhase 3NCT06448312
Nov 2026Sinovac Biotechexperimental vaccine, active comparator vaccineEpidemic Meningitis, Meningococcal VaccinesPhase 3NCT07505888
Nov 2026Waterstone Pharmaceutical (Wuhan) Co., LTD.WS016HyperkalemiaPhase 3NCT07251309
Nov 2026Wooshin Labottach Co., Ltd.Cosmetic patch containing urea applicated daily for 3 monthsNail Psoriasis, Nail Damage and 1 morePhase 3NCT07029516
Nov 2026medac GmbHMethotrexateModerate to Severe Atopic DermatitisPhase 3NCT06239311
Nov 1, 2026Bristol-Myers SquibbKarXTBipolar-I Disorder With Mania or Mania With Mixed FeaturesPhase 3NCT06951698
Nov 1, 2026EpygenixClemizole HClLennox Gastaut SyndromePhase 3NCT05066217
Nov 1, 2026Scholar Rock, Inc.ApitegromabSpinal Muscular Atrophy, Spinal Muscular Atrophy Type 3 and 8 morePhase 3NCT05626855
Nov 2, 2026AstraZenecaAnifrolumabCutaneous Lupus ErythematosusPhase 3NCT06015737
Nov 2, 2026Bristol-Myers SquibbKarXTBipolar Disorder Type I With Mania or Mania With Mixed FeaturesPhase 3NCT06951711
Nov 2, 2026Teva Pharmaceutical Industries Ltd.Fp/ABS, FP, ABSAsthmaPhase 3NCT06664619
Nov 3, 2026NovartisLOU064 (blinded)Chronic Spontaneous UrticariaPhase 3NCT05677451
Nov 4, 2026CMG Pharmaceutical Co. LtdCMG190303(Dapagliflozin/Rosuvastatin)Dyslipidemia, Type 2 DiabetesPhase 3NCT06772168
Nov 9, 2026LEAF4Life, Inc.LEAF-4L6715, Supportive CareAcute Respiratory Distress SyndromePhase 3NCT06640777
Nov 10, 2026Gan & Lee Pharmaceuticals Co., Ltd.GZR4, Insulin Icodec groupDiabetesPhase 3NCT07165223
Nov 10, 2026LaNova Medicines Zhejiang Co., Ltd.LM-302, Apatinib, IrinotecanLocally Advanced or Metastatic GC and GCJ AdenocarcinomaPhase 3NCT06351020
Nov 11, 2026AstraZenecaTrastuzumab deruxtecan, Taxane, Pertuzumab and 1 moreBreast Cancer; HER2-positive; MetastaticPhase 3NCT04784715
Nov 11, 2026Tasly Pharmaceutical Group Co., LtdChangkang granulesDiarrhea-predominant Irritable Boewl SyndromePhase 3NCT06753890
Nov 12, 2026Qilu Pharmaceutical Co., Ltd.RelugolixHeavy Menstrual Bleeding, Uterine FibroidsPhase 3NCT06671548
Nov 13, 2026Roche HoldingInavolisib, Fulvestrant, Alpelisib and 3 moreBreast CancerPhase 3NCT05646862
Nov 14, 2026BrightGene Bio-Medical Technology Co.5 mg BGM0504 Administered SC, 10 mg BGM0504 Administered SC, Semaglutide Administered SCType 2 Diabetes Mellitus (T2DM)Phase 3NCT06716216
Nov 14, 2026BrightGene Bio-Medical Technology Co.5 mg BGM0504 Administered SC, : 10 mg BGM0504 Administered SCType 2 Diabetes Mellitus (T2DM)Phase 3NCT06716203
Nov 15, 2026Achieve Life Sciences, INC.Cytisinicline, Behavioral SupportVaping CessationPhase 3NCT07392125
Nov 16, 2026UCBZilucoplanGeneralized Myasthenia GravisPhase 2/3NCT06055959
Nov 18, 2026Bristol-Myers SquibbDeucravacitinibSjögren's SyndromePhase 3NCT05946941
Nov 18, 2026Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB ChairETOPOSIDE - Usual, ETOPOSIDE - StudySmall Cell Lung CancerPhase 2/3NCT01064466
Nov 18, 2026Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairAbiraterone - Usual, Abiraterone - StudyProstate CancerPhase 2/3NCT03348670
Nov 18, 2026Medicine Invention Design, IncALECENSA - alectinib hydrochloride capsuleALK-Positive Non-Small Cell Lung Cancer (NSCLC)Phase 2/3NCT05987956
Nov 20, 2026Merck & Co.Pembrolizumab, Carboplatin, Paclitaxel and 5 moreEndometrial NeoplasmsPhase 3NCT04634877
Nov 21, 2026Changchun GeneScience Pharmaceutical Co., Ltd.Cabergoline tablets, Bromocriptine mesylate tabletsHyperprolactinemiaPhase 3NCT07124221
Nov 23, 2026GSKdTpaDiphtheria-Tetanus-acellular Pertussis VaccinesPhase 3NCT07596199
Nov 23, 2026GSKInvestigational varicella vaccine, Marketed varicella vaccine, Measles, mumps, and rubella vaccine and 4 moreChickenpoxPhase 3NCT06693895
Nov 24, 2026Merck KGaAAvelumabSolid TumorsPhase 3NCT03815643
Nov 24, 2026HTA Co., Ltd.177Lu-DOTATATE injection, Octreotide LAR (Long-acting release)NETS Ga68 Lu177Phase 3NCT07057622
Nov 24, 2026Bristol-Myers SquibbKarXTAlzheimer DiseasePhase 3NCT06585787
Nov 25, 2026Beijing InnoCare Pharma Tech Co., Ltd.ICP-332 TabletsAtopic DermatitisPhase 3NCT06775860
Nov 26, 2026Shaanxi Micot Pharmaceutical Technology Co., Ltd.MT1013, CinacalcetSecondary Hyperparathyroidism, Chronic Kidney DiseasePhase 3NCT07122401
Nov 26, 2026GSKDostarlimab, Carboplatin, Paclitaxel and 1 moreNeoplasmsPhase 3NCT03981796
Nov 28, 2026Haisco Pharmaceutical Group Co., Ltd.HSK31858, tabletNon-cystic Fibrosis BronchiectasisPhase 3NCT06660992
Nov 28, 2026SanofiYellow fever vaccine (live), Measles, combinations with mumps and rubella, live attenua…Yellow Fever ImmunizationPhase 3NCT07103148
Nov 29, 2026PfizerRimegepantMenstrual MigrainePhase 3NCT06641466
Nov 30, 2026AUG TherapeuticsAVTX-803 (L-Fucose)Leukocyte Adhesion DeficiencyPhase 3NCT05462587
Nov 30, 2026CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.Plasmodium immunotherapyAdvanced Ovarian CancerPhase 2/3NCT05924776
Nov 30, 2026Cytopeutics Sdn. Bhd.Neuroncell-EXAcute Ischemic StrokePhase 2/3NCT06129175
Nov 30, 2026Gritgen Therapeutics Co., Ltd.GS1191-0445 injectionHemophilia APhase 3NCT06833983
Nov 30, 2026Roche HoldingAtezolizumab, BevacizumabCancerPhase 3NCT03148418
Nov 30, 2026InventisBio Co., LtdD-0502, FulvestrantBreast CancerPhase 3NCT06954961
Nov 30, 2026Pharming Technologies B.V.LeniolisibAPDSPhase 3NCT05438407
Nov 30, 2026SanofirilzabrutinibImmune ThrombocytopeniaPhase 3NCT07216079
Nov 30, 2026Saol Therapeutics IncSL1002, Normal SalineOsteoarthritis Knee PainPhase 3NCT07226258
Nov 30, 2026Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.A166, T-DM1HER2-positive Breast CancerPhase 3NCT06968585
Nov 30, 2026Taisho Pharmaceutical Co., Ltd.TS-172 20~60 mg/dayHyperphosphatemia Patients on HemodialysisPhase 3NCT07548840
Nov 30, 2026Tolmar Inc.TOL2506, Tamoxifen, Letrozole Tablets and 2 moreBreast CancerPhase 3NCT04906395
Nov 30, 2026Zhejiang Wenda Pharma Technology LTD.WD-890Moderate to Severe Plaque PsoriasisPhase 3NCT07672561

115 phase 2 readouts too. All 187 phase 2 and 3 readouts in Nov 2026

December 2026

Phase 3 readouts: 196

Primary completionSponsorDrugConditionPhaseRecord
Dec 2026AbbVieABBV-RGX-314, Ranibizumab (LUCENTIS®)AMD, nAMD and 7 morePhase 2/3NCT04704921
Dec 2026AbbVieLutikizumabHidradenitis SuppurativaPhase 3NCT06468228
Dec 2026AkesoAK112, Nab-paclitaxelTriple-Negative Breast Cancer (TNBC)Phase 3NCT06767527
Dec 2026Aldeyra Therapeutics, Inc.ICM ADX-2191 injection, Monthly ADX-2191 injectionPrimary Vitreoretinal LymphomaPhase 3NCT07402876
Dec 2026Allist Pharmaceuticals, Inc.Furmonertinib 80 mgNon-small Cell Lung CarcinomaPhase 3NCT04853342
Dec 2026Astria Therapeutics, Inc.navenibartHereditary Angioedema (HAE)Phase 3NCT06842823
Dec 2026Atea Pharmaceuticals, Inc.Bemnifosbuvir-Ruzasvir, Sofosbuvir-VelpatasvirHEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic and 2 morePhase 3NCT07037277
Dec 2026Axsome TherapeuticsSolriamfetol 150 mg, Solriamfetol 300 mgBinge-Eating DisorderPhase 3NCT06413433
Dec 2026Axsome TherapeuticsSolriamfetol 150 mg, Solriamfetol 300 mgExcessive Sleepiness, Shift-work DisorderPhase 3NCT06568367
Dec 2026Azidus Brasil–Covid 19, InfluenzaPhase 3NCT06817096
Dec 2026Biohaven PharmaceuticalsBHV-7000Focal EpilepsyPhase 2/3NCT06132893
Dec 2026Boryung Pharmaceutical Co., LtdBR1019A, BR1019B, BR1019C and 3 moreEssential Hypertension, Type 2 Diabetes MellitusPhase 3NCT06220773
Dec 2026CelltrionMetformin, Alogliptin, empagliflozinT2DM, Diabete Type 2 and 1 morePhase 3NCT07093476
Dec 2026Chengdu Kangnuoxing Biopharma,Inc.StapokibartSeasonal Allergic Rhinitis (SAR)Phase 3NCT07678931
Dec 2026Sino Biopharmaceutical LimitedAK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate TabletsAdvanced Hepatocellular Carcinoma (HCC)Phase 3NCT04344158
Dec 2026Sino Biopharmaceutical LimitedTQB3454 tabletsBiliary CarcinomaPhase 3NCT05987358
Dec 2026Sino Biopharmaceutical LimitedTQB3616 capsules, Letrozole, Anastrozole, TamoxifenBreast CancerPhase 3NCT05780567
Dec 2026Cook MyoSiteIltamiocelFecal IncontinencePhase 3NCT05776277
Dec 2026DiaMedica Therapeutics Inc.Recombinant human tissue kallikreinAcute Stroke, Ischemic Stroke and 1 morePhase 2/3NCT05065216
Dec 2026Dr. Falk Pharma GmbHBudesonideEosinophilic EsophagitisPhase 3NCT06596252
Dec 2026Fujian Shengdi Pharmaceutical Co., Ltd.HRS9531Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP TherapyPhase 3NCT06994650
Dec 2026Fujian Shengdi Pharmaceutical Co., Ltd.HRS9531Bstructive Sleep Apnea (OSA) and ObesityPhase 3NCT06974851
Dec 2026GC Cell CorporationImmuncell-LC, GemcitabinePancreatic Ductal AdenocarcinomaPhase 3NCT04969731
Dec 2026Genelux Corporationolvimulogene nanivacirepvec, Platinum chemotherapy: carboplatin (preferred) or cisplatin, Non-platinum chemotherapy: Physician's Choice of gemcitabi… and 1 morePlatinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer and 5 morePhase 3NCT05281471
Dec 2026Gilead SciencesSacituzumab Govitecan-hziy, Eribulin Mesylate Injection, Capecitabine Oral Product and 2 moreMetastatic Breast CancerPhase 3NCT04639986
Dec 2026Gossamer Bio, Inc.Seralutinib, Gereic Dry Powder InhalerPulmonary Arterial HypertensionPhase 3NCT06274801
Dec 2026Grand Shuyang Life Sciences (Chengdu) Co., Ltd.Human immunoglobulin (pH4) for intravenous injectionPrimary Immune Thrombocytopenia (ITP)Phase 3NCT07233213
Dec 2026Jiangsu Hengrui MedicineSHR-1819 InjectionSeasonal Allergic RhinitisPhase 3NCT07688772
Dec 2026Harrow HealthSham (No Treatment), TRIESENCE (triamcinolone acetonide injectable suspension)Postoperative Ocular Inflammation, Postoperative Ocular PainPhase 3NCT07832552
Dec 2026Inmunotek S.L.10,000 MM09, 30,000 MM09Rhinitis, Allergic, Rhinoconjunctivitis and 1 morePhase 3NCT04435990
Dec 2026Intra-IMMUSG Pte LtdPRL3-ZUMABAdvanced Solid CancersPhase 2/3NCT07290088
Dec 2026Ionis Pharmaceuticals IncDonidalorsenHereditary AngioedemaPhase 3NCT05392114
Dec 2026Jiangsu Hengrui MedicineLutetium (177Lu) Oxodotreotide Injection；long-acting Octre…, long-acting OctreotideAdvanced Gastroenteropancreatic Neuroendocrine TumorPhase 3NCT05884255
Dec 2026Karyopharm Therapeutics Inc.Selinexor (combination therapy), Rituximab (combination therapy), Gemcitabine (combination therapy) and 3 moreRelapsed/Refractory Diffuse Large B-cell LymphomaPhase 2/3NCT04442022
Dec 2026Kedrion S.p.A.Kedrion IVIG 10%Chronic Primary Immune Thrombocytopenia (ITP)Phase 3NCT07059000
Dec 2026Kedrion S.p.A.Kedrion IVIG 10%Primary Immunodeficiency DiseasePhase 3NCT04944979
Dec 2026Krystal Biotech, Inc.KB803Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa and 2 morePhase 3NCT07016750
Dec 2026Mabscale, LLCBevacizumab, Paclitaxel, CarboplatinNon-Small Cell Lung CancerPhase 3NCT05654454
Dec 2026Madrigal Pharmaceuticals, INC.ResmetiromNASH, Cirrhosis, LiverPhase 3NCT05500222
Dec 2026MediWound Ltd.EscharEx (EX-03)Venous Leg Ulcer (VLU)Phase 3NCT06568627
Dec 2026Minghui Pharmaceutical (Hangzhou) LtdMHB018AThyroid Associated OphthalmopathiesPhase 3NCT06989918
Dec 2026Nanjing Chia-tai Tianqing PharmaceuticalRamelteonChronic InsomniaPhase 3NCT06512363
Dec 2026Napo Pharmaceuticals, Inc.Crofelemer Powder for Oral SolutionMicrovillus Inclusion Disease, Congenital Disorders and 1 morePhase 2/3NCT06721871
Dec 2026OctapharmaOCTA-C1-INHAcute Hereditary Angio EdemaPhase 3NCT06361537
Dec 2026OculisArtificial Tear Run-in, licaminlimabDry Eye Disease (DED)Phase 2/3NCT07548632
Dec 2026Otsuka PharmaceuticalOPA-15406Atopic Dermatitis (AD)Phase 3NCT07173478
Dec 2026Pacira Pharmaceuticals, Inc.ZILRETTAGlenohumeral OsteoarthritisPhase 3NCT06269705
Dec 2026Praxis Precision Medicines, Inc.1mg elsunersen, 0.5mg elsunersenEpileptic Encephalopathy, SCN2A EncephalopathyPhase 3NCT07019922
Dec 2026Praxis Precision Medicines, Inc.1.0mg/kg/day PRAX-562, 1.5mg/kg/day PRAX-562Developmental and Epileptic Encephalopathy 1Phase 3NCT07010471
Dec 2026Prove pharmIndigotindisulfonate sodium 0.8% injectionUreter InjuryPhase 3NCT06448143
Dec 2026Qilu Pharmaceutical Co., Ltd.Meropenem and Pralurbactam, Best Available Therapy (e.g., colistin, meropenem, tegecyc…Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP) and 3 morePhase 3NCT07089186
Dec 2026Qilu Pharmaceutical Co., Ltd.QL2107, Pemetrexed, Carboplatin and 1 moreNSCLCPhase 3NCT06754644
Dec 2026Qilu Pharmaceutical Co., Ltd.QLG1091, RybelsusType 2 DiabetesPhase 3NCT07487103
Dec 2026Qilu Pharmaceutical Co., Ltd.QL1207H injection, Aflibercept 8 mgNeovascular Age-Related Macular Degeneration (nAMD)Phase 3NCT07489586
Dec 2026RayzeBio, Inc.RYZ101, Everolimus, Sunitinib and 2 moreGEP-NET, Gastroenteropancreatic Neuroendocrine Tumor and 5 morePhase 3NCT05477576
Dec 2026RemeGen Co., Ltd.Disitamab Vedotin Injection, Cadonilimab Injection, Paclitaxel InjectionGastric Cancer, Gastroesophageal Junction AdenocarcinomaPhase 2/3NCT06221748
Dec 2026Sichuan Baili Pharmaceutical Co., Ltd.BL-B01D1, DocetaxelNon-small Cell Lung CancerPhase 3NCT06382129
Dec 2026Sichuan Baili Pharmaceutical Co., Ltd.BL-B01D1, TopotecanSmall Cell Lung CancerPhase 3NCT06500026
Dec 2026Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SKB264, Pembrolizumab, pemetrexed and 1 moreNon-Small Cell Lung CancerPhase 3NCT06711900
Dec 2026Sound Pharmaceuticals, IncorporatedEbselenMeniere's Disease, Ménière's DiseasePhase 3NCT06859788
Dec 2026Suven Life Sciences LimitedMasupirdine 50 mg, Masupirdine 100 mgAgitation, Alzheimer's Type DementiaPhase 3NCT05397639
Dec 2026Jiangsu Hengrui MedicineSHR-A2009 monotherapy, platinum-based dual-agent chemotherapyNon-small Cell Lung CancerPhase 3NCT06671379
Dec 2026TR Therapeutics–Venous Leg Ulcer, Venous Ulcer and 6 morePhase 3NCT06707103
Dec 2026Tasly Pharmaceuticals, Inc.T89 capsuleChronic Stable Angina PectorisPhase 3NCT03789552
Dec 2026TransThera Sciences (Nanjing), Inc.Tinengotinib 8 mg, Tinengotinib 10 mg, Physician's ChoiceCholangiocarcinomaPhase 3NCT05948475
Dec 2026UNITED THERAPEUTICS CorpRalinepagPAH, Pulmonary Hypertension and 9 morePhase 3NCT03683186
Dec 2026VIS, Inc.Optimal laser keratoplastyPresbyopiaPhase 3NCT06487897
Dec 2026Vanda Pharmaceuticals Inc.VQW-765Social Anxiety Disorder (SAD)Phase 3NCT07221578
Dec 2026Veradermics, IncVDPHL01Androgenetic Alopecia, AGA and 1 morePhase 3NCT06972264
Dec 2026Vergent Bioscience, Inc.Abenacianine, Near Infrared (NIR) ImagingLung Cancer, Lung MetastasesPhase 3NCT07499674
Dec 2026VIR BiotechnologyTobevibart, Elebsiran, BulevirtideViral HepatitisPhase 3NCT07128550
Dec 2026Wuxi Cellular Biopharmaceutical Group Ltd.Mesenchymal Stem Cells, Sodium Hyaluronate InjectionKnee OsteoarthritisPhase 3NCT06570291
Dec 2026iCoat Medical ABiCM012 solution 2 mg/mLIschemia-reperfusion Injury, Kidney Transplant; ComplicationsPhase 2/3NCT06582485
Dec 1, 2026BiogenFelzartamabAntibody-mediated RejectionPhase 3NCT06685757
Dec 1, 2026Fujian Akeylink Biotechnology Co., Ltd.GST-HG141Chronic Hepatitis bPhase 3NCT07090759
Dec 1, 2026Guangdong Raynovent Biotech Co., LtdRAY1225, SemaglutideT2DMPhase 3NCT07139548
Dec 1, 2026Guangdong Raynovent Biotech Co., LtdRAY1225T2DMPhase 3NCT07139535
Dec 1, 2026HealthBio, Inc.Maraviroc (MVC), Atorvastatin, 10mg, 20mg, 40mgLong COVIDPhase 2/3NCT06974084
Dec 1, 2026JYAMS PET Research & Development Limited[18F]-APN-1607Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) DementiaPhase 3NCT07422857
Dec 1, 2026Johnson & JohnsonApalutamide, Androgen Deprivation Therapy (ADT)Prostatic NeoplasmsPhase 3NCT03767244
Dec 1, 2026Kind Pharmaceuticals LLCAND017, ESAAnemia Due to Chronic Kidney DiseasePhase 3NCT07487727
Dec 1, 2026OctapharmaAtenativCongenital Antithrombin DeficiencyPhase 3NCT04918173
Dec 1, 2026SanofiPCV21, 20vPCVPneumococcal InfectionsPhase 3NCT06838000
Dec 1, 2026Shanghai PharmaceuticalsSPH4336 TabletsLocally Advanced or Metastatic Breast CancerPhase 2/3NCT05860465
Dec 1, 2026Shanghai Vitalgen BioPharma Co., Ltd.VGR-R01Bietti Crystalline Dystrophy, Inherited Retinal DiseasesPhase 3NCT06699108
Dec 1, 2026Tasly Pharmaceutical Group Co., LtdJitongning tablets, a simulated agent of Jitongning tabletsAnkylosing SpondylitisPhase 3NCT06000956
Dec 1, 2026Vanda Pharmaceuticals Inc.TradipitantNausea and Vomiting, ObesityPhase 3NCT07446439
Dec 1, 2026Virchow GroupIVIG-VImmune, IVIG-ImmugloPrimary Immunodeficiency Diseases (PID)Phase 3NCT07017036
Dec 2, 2026PfizerPF-06821497, EnzalutamideMetastatic Castration-Resistant Prostate CancerPhase 3NCT06629779
Dec 2, 2026PfizerRitlecitinib higher dose, Ritlecitinib lower doseSevere Alopecia AreataPhase 3NCT07029711
Dec 4, 2026PfizerVLA15Lyme DiseasePhase 3NCT07500506
Dec 7, 2026AstraZenecaeculizumabNMOSD, Neuromyelitis Optica Spectrum DisordersPhase 3NCT06724809
Dec 8, 2026Johnson & JohnsonMilvexian, ApixabanAtrial FibrillationPhase 3NCT05757869
Dec 9, 2026Bristol-Myers SquibbKarXTPsychosis Associated With Alzheimer's DiseasePhase 3NCT06126224
Dec 10, 2026Boehringer Ingelheimzongertinib, pembrolizumab, cisplatin and 2 moreLung Cancer, Non-squamous, Non-small CellPhase 3NCT06151574
Dec 11, 2026Gan & Lee Pharmaceuticals Co., Ltd.GZR18, semaglutideType 2 Diabetes Mellitus (T2DM)Phase 3NCT06778967
Dec 12, 2026CSPC Pharmaceutical GroupSYS6010, Osimertinib, platinum-pemetrexedNSCLCPhase 3NCT07376382
Dec 13, 2026Jiangsu Hengrui Medicine–Psoriatic ArthritisPhase 3NCT04957550
Dec 14, 2026AmgenABP 234, PembrolizumabEarly-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)Phase 3NCT06430866
Dec 14, 2026GSKInvestigational varicella vaccine, Marketed varicella vaccine, MMR vaccine and 4 moreChickenpoxPhase 3NCT06806137
Dec 15, 2026AstraZenecaGefurulimabGeneralized Myasthenia Gravis, gMGPhase 3NCT06607627
Dec 15, 2026ExelixisXL092, Nivolumab, Sunitinib MalateNon-Clear Cell Renal Cell CarcinomaPhase 3NCT05678673
Dec 15, 2026Gedeon Richter Ltd.CariprazineSchizophreniaPhase 3NCT03817502
Dec 15, 2026IpsenCorabotaseModerate to Severe Glabellar LinesPhase 3NCT07435428
Dec 15, 2026IpsenCorabotaseModerate to Severe Glabellar LinesPhase 3NCT07427797
Dec 16, 2026Roche HoldingSatralizumabNMDAR Autoimmune Encephalitis, LGI1 Autoimmune EncephalitisPhase 3NCT05503264
Dec 16, 2026Shanghai JMT-Bio Inc.KN026, HB1801, Pertuzumab and 3 moreEarly or Locally Advanced HER2-positive Breast CancerPhase 3NCT06747338
Dec 17, 2026IpsenElafibranorPrimary Biliary CholangitisPhase 3NCT06730061
Dec 18, 2026Ausper Biopharma Co., Ltd.AHB-137, NA therapyChronic Hepatitis BPhase 3NCT07246889
Dec 18, 2026Han Xu, M.D., Ph.D., FAPCR, Medical Director, IRB ChairTopotecan - usual, Topotecan - studySCLCPhase 2/3NCT07145333
Dec 18, 2026Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairRaloxifene - Usual, Raloxifene - StudyBreast CancerPhase 2/3NCT06062810
Dec 20, 2026TJ Biopharma Co., Ltd.PlonmarlimabRelapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic LymphohistiocytosisPhase 3NCT07208058
Dec 21, 2026UCBBimekizumabHidradenitis SuppurativaPhase 3NCT06921850
Dec 22, 2026Adverum Biotechnologies, Inc.Ixo-vec, AfliberceptNeovascular Age-Related Macular Degeneration (nAMD), Wet AMDPhase 3NCT06856577
Dec 22, 2026Taisho Pharmaceutical Co., Ltd.TS-172 20~60 mg/dayHyperphosphatemia Patients on HemodialysisPhase 3NCT07285291
Dec 23, 2026AstraZenecaBenralizumabAsthmaPhase 3NCT05692180
Dec 23, 2026OncoZenge ABBupiZenge 25 mg, Lidocaine viscous 2%Head & Neck Cancer, Oral MucositisPhase 3NCT07672236
Dec 23, 2026R-BioJOINTSTEMKnee OsteoarthritisPhase 3NCT04427930
Dec 24, 2026Shanghai Kechow Pharma, Inc.Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemothera…Colorectal Cancer MetastaticPhase 3NCT06008119
Dec 25, 2026GSKInvestigational varicella vaccine_Lot 1, Investigational varicella vaccine_Lot 2, Investigational varicella vaccine_Lot 3 and 7 moreChickenpoxPhase 3NCT06740630
Dec 25, 2026Jiangsu Healthy Life Innovation Medical Technology Co., LtdTumor treating fields combined with Gemcitabine hydrochlor…, Gemcitabine hydrochloride and albumin binding paclitaxelLocally Advanced Pancreatic CancerPhase 3NCT05653453
Dec 26, 2026CanariaBio Inc.Oregovomab, Paclitaxel, CarboplatinCarcinoma, Ovarian Epithelial, Ovarian Neoplasms and 8 morePhase 3NCT04498117
Dec 26, 2026IncytePovorcitinibHidradenitis Suppurativa (HS)Phase 3NCT06212999
Dec 28, 2026Jiangsu Topcel-KH Pharmaceutical Co., Ltd.Human TH-SC01 cell injection, Saline solutionCrohn's DiseasePhase 3NCT06925594
Dec 28, 2026PfizerPF-06821497, Docetaxel, EnzalutamideMetastatic Castrate Resistant Prostate Cancer (mCRPC)Phase 3NCT06551324
Dec 30, 2026AskGene Pharma, Inc.ASKB589, Oxaliplatin, Capecitabine and 1 moreGastroesophageal Junction Adenocarcinoma, Gastric AdenocarcinomaPhase 3NCT06206733
Dec 30, 2026Beijing Continent Pharmaceutical Co, Ltd.Pirfenidone Capsules （400 mg）, Pirfenidone Capsules（600mg）, Pirfenidone Capsules（0mg）Radiation-induced Lung Injury, Immune-related PneumoniaPhase 2/3NCT07388680
Dec 30, 2026Beijing Konruns Pharmaceutical Co., Ltd.KC1036, Irinotecan, Docetaxel and 1 moreEsophageal Squamous Cell CarcinomaPhase 3NCT06194734
Dec 30, 2026Cartesian TherapeuticsDecartes-08Myasthaenia GravisPhase 3NCT06799247
Dec 30, 2026Ebima Clifford OkundayeQRX-3Acute Renal Failure (ARF), Acute Tubular NecrosisPhase 2/3NCT07161843
Dec 30, 2026Getz PharmaAcotiamidePostprandial Distress SyndromePhase 3NCT07174297
Dec 30, 2026Innovent BiologicsIrinotecan OR Paclitaxel or Trifluridine/tipiracil（ FTD/TPI）, IBI343Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPhase 3NCT06238843
Dec 30, 2026Johnson & JohnsonCetrelimab, TAR-200, Cisplatin and 3 moreUrinary Bladder NeoplasmsPhase 3NCT04658862
Dec 30, 2026Johnson & JohnsonSeltorexant, Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-No…Depressive Disorder, MajorPhase 3NCT06559306
Dec 30, 2026Jiangsu Alphamab Biopharmaceuticals Co., LtdJSKN003, Doxorubicin, Paclitaxel and 1 moreOvarian Cancer, Primary Peritoneal and 1 morePhase 3NCT06751485
Dec 30, 2026Jiangsu vcare pharmaceutical technology co., LTDVicagrel, ClopidogrelAcute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Phase 3NCT06577519
Dec 30, 2026Jiangsu vcare pharmaceutical technology co., LTDVC004 CapsulesLocally Advanced Solid TumorPhase 3NCT06658353
Dec 30, 2026NovartiseverolimusTuberous Sclerosis ComplexPhase 3NCT02962414
Dec 30, 2026PfizerVepdegestrant (ARV-471/PF-07850327), Palbociclib, LetrozoleBreast CancerPhase 3NCT05909397
Dec 30, 2026Quoin Pharmaceuticals Ltd.QRX003, 4% LotionNetherton SyndromePhase 2/3NCT06953466
Dec 30, 2026Quoin Pharmaceuticals Ltd.QRX003, 4% LotionNetherton SyndromePhase 2/3NCT05789056
Dec 30, 2026Shanghai Jiaolian Drug Research and Development Co., LtdB007Generalized Myasthenia GravisPhase 2/3NCT06447597
Dec 30, 2026Sinovac BiotechRabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verorab®RabiesPhase 3NCT07055295
Dec 30, 2026Wuhan Createrna Science and Technology Co., LtdMY008211A tabletsParoxysmal Nocturnal Hemoglobinuria (PNH)Phase 2/3NCT06933914
Dec 30, 2026Xynomic Pharmaceuticals, Inc.Pazopanib, AbexinostatRenal Cell CarcinomaPhase 3NCT03592472
Dec 31, 2026AMO Pharma LimitedTideglusibCongenital Myotonic DystrophyPhase 2/3NCT05004129
Dec 31, 2026AUG TherapeuticsAVTX-803Leukocyte Adhesion DeficiencyPhase 3NCT05754450
Dec 31, 2026Albireo, an Ipsen CompanyOdevixibatAlagille SyndromePhase 3NCT05035030
Dec 31, 2026Amicus Therapeuticsmigalastat HCl 150 mgFabry DiseasePhase 3NCT04020055
Dec 31, 2026Ascentage Pharma Group Internationallisaftoclax +BTK inhibitor, BTK inhibitorCLL/SLLPhase 3NCT06104566
Dec 31, 2026AstraZenecaDurvalumabCancerPhase 3NCT05303532
Dec 31, 2026BeOne Medicines Ltd.Zanubrutinib, TislelizumabB-cell MalignanciesPhase 3NCT04170283
Dec 31, 2026Biocity Biopharmaceutics Co., Ltd.SC0062 strength 10mgIgA Nephropathy (IgAN)Phase 3NCT06819826
Dec 31, 2026Boehringer IngelheimBI 690517, EmpagliflozinKidney Disease, ChronicPhase 3NCT06531824
Dec 31, 2026Changchun GeneScience Pharmaceutical Co., Ltd.Nano-crystalline Megestrol Acetate Oral Suspension, standard treatmentExtensive-stage Small Cell Lung Cancer (ES-SCLC), The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative TherapyPhase 3NCT06961201
Dec 31, 2026Clarity Pharmaceuticals Ltd64Cu-SAR-bisPSMAProstate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy and 4 morePhase 3NCT06970847
Dec 31, 2026Cloudbreak Therapeutics, LLCCBT-001PterygiumPhase 3NCT05456425
Dec 31, 2026Corza Medical GmbHTachoSil, Surgicel OriginalHemorrhagePhase 3NCT06664775
Dec 31, 2026EisaiLecanemab IV, Lecanemab SCEarly Alzheimer's DiseasePhase 3NCT03887455
Dec 31, 2026Galderma Group AG/ADRTrifaroteneAcne VulgarisPhase 3NCT07186413
Dec 31, 2026GeneCradle IncGC101 adeno-associated virus injectionSMA - Spinal Muscular AtrophyPhase 3NCT06971094
Dec 31, 2026Guangzhou JOYO Pharma Co., LtdSC1011Idiopathic Pulmonary FibrosisPhase 2/3NCT06125327
Dec 31, 2026HK inno.N CorporationIN-B00009Obesity &Amp; OverweightPhase 3NCT07192263
Dec 31, 2026Hangzhou Gensciences Biopharmaceutical Co., Ltd.FRSW107Severe Hemophilia APhase 3NCT06136507
Dec 31, 2026Hangzhou Highlightll Pharmaceutical Co., LtdTLL-018Rheumatoid ArthritisPhase 3NCT06887127
Dec 31, 2026Roche HoldingPertuzumab, Trastuzumab, Other Combination Anti-Cancer TherapiesSolid TumorsPhase 3NCT02320435
Dec 31, 2026Roche HoldingInavolisib, Phesgo, Taxane-based Chemotherapy and 1 moreMetastatic Breast CancerPhase 3NCT05894239
Dec 31, 2026Innovent BiologicsIBI362, semaglutideOverweight, Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Phase 3NCT06884293
Dec 31, 2026Innovent BiologicsIBI311Thyroid Eye DiseasePhase 3NCT07113262
Dec 31, 2026INSMED IncTreprostinil PalmitilPulmonary Arterial HypertensionPhase 2/3NCT05649748
Dec 31, 2026Iperboreal Pharma SrlXyloCore Low Strenght, XyloCore Medium Strenght, XyloCore …, 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD SolutionEnd Stage Renal DiseasePhase 3NCT03994471
Dec 31, 2026Johnson & JohnsonIbrutinibChronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma and 5 morePhase 3NCT01804686
Dec 31, 2026Jiangsu Hengrui MedicineSHR-A1811, Pyrotinib in combination with Capecitabine.HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and TaxanePhase 3NCT05424835
Dec 31, 2026Jiangsu Hengrui MedicineFuzuloparib , Abiraterone acetate and PrednisoneMetastatic Castration-Resistant Prostate Cancer (mCRPC)Phase 3NCT04691804
Dec 31, 2026Jiangsu Hengrui MedicineHRS-9190, RocuroniumNeuromuscular BlockadePhase 3NCT07746726
Dec 31, 2026Kartos Therapeutics, Inc.Navtemadlin, RuxolitinibMyelofibrosis, Post-PV MF and 3 morePhase 3NCT06479135
Dec 31, 2026Laboratorios Silanes S.A. de C.V.Etoricoxib + Betamethasone fixed dose, Etoricoxib fixed doseGout Arthritis, Gout AttackPhase 3NCT06863701
Dec 31, 2026Longboard Pharmaceuticals, Inc.LP352Dravet SyndromePhase 3NCT06660394
Dec 31, 2026Materia Medica HoldingRaphaminCystitis Chronic, Cystitis Bacterial and 1 morePhase 3NCT06284265
Dec 31, 2026NaviFUS CorporationBevacizumab, Microbubble, Low-Intensity Focused UltrasoundGlioblastoma Multiforme, Glioblastoma and 6 morePhase 3NCT06496971
Dec 31, 2026Olatec Therapeutics, Inc.DapansutrileAcute Gout Flare, Gout Attack and 5 morePhase 2/3NCT05658575
Dec 31, 2026PT Bio FarmaQuadrivalent Human Papillomavirus (Types 6,11,16,18) Recom…, Tetanus-Diphtheria boosterHuman Papillomavirus (HPV) InfectionPhase 3NCT07824310
Dec 31, 2026PfizerAvelumab, Lorlatanib, Talazoparib and 5 moreAdvanced Malignancies, NSCLC and 3 morePhase 3NCT05059522
Dec 31, 2026Qilu Pharmaceutical Co., Ltd.QL2107, Keytruda®Carcinoma, Non-Small-Cell LungPhase 3NCT07162883
Dec 31, 2026RemeGen Co., Ltd.RC48-ADC, Toripalimab, Gemcitabine and 2 moreUrothelial Carcinoma, HER2-expressingPhase 3NCT05302284
Dec 31, 2026RemeGen Co., Ltd.TelitaciceptMyasthenia Gravis, OcularPhase 3NCT07249632
Dec 31, 2026Serum Institute of India Pvt. Ltd.Cervavac as three dose regimen, Cervavac as two dose regimen, Gardasil as three dose regimenHuman Papillomavirus InfectionPhase 3NCT06281119
Dec 31, 2026Shanghai Jiaolian Drug Research and Development Co., LtdB007PemphigusPhase 2/3NCT06454357
Dec 31, 2026Shanghai Jiaolian Drug Research and Development Co., LtdB007, Cyclosporin CapsulesPrimary Membranous NephropathyPhase 2/3NCT06470191
Dec 31, 2026Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SKB264, Eribulin, Capecitabine and 2 moreMetastatic Breast CancerPhase 3NCT06081959
Dec 31, 2026TRB ChemedicaArtrodarKnee OsteoarthritisPhase 3NCT04318041
Dec 31, 2026Tasly Pharmaceutical Group Co., LtdLianxiaxiaopi Granules, a simulated agent of Lianxiaxiaopi GranulesPostprandial Distress SyndromePhase 3NCT06696261
Dec 31, 2026Tasly Pharmaceutical Group Co., LtdJS1-1-01 low-dose group, JS1-1-01 high-dose groupDepressionPhase 2/3NCT07485595
Dec 31, 2026ViatrisCenerimodLupus Erythematosus, SystemicPhase 3NCT05672576
Dec 31, 2026VIR BiotechnologyTobevibart, ElebsiranViral HepatitisPhase 3NCT06903338
Dec 31, 2026VivaVision Biotech, IncVVN461 Ophthalmic Solution 1.0%, 1.0% prednisolone acetateNon-infectious Anterior UveitisPhase 3NCT07136805

359 phase 2 readouts too. All 555 phase 2 and 3 readouts in Dec 2026

January 2027

Phase 3 readouts: 73

Primary completionSponsorDrugConditionPhaseRecord
Jan 2027A. Menarini International Licensing S.A.–Mixed Dyslipidemia, HypercholesterolaemiaPhase 3NCT07614958
Jan 2027AbbVieUpadacitinibAtopic DermatitisPhase 3NCT06701331
Jan 2027AbbVieLivmoniplimab, Budigalimab, Durvalumab and 3 moreHepatocellular CarcinomaPhase 2/3NCT06109272
Jan 2027Adneuris Therapeutics, Inc.Cebranopadol 400 ugPainPhase 3NCT07845071
Jan 2027AkesoAK117 in combination with AK112Head and Neck Squamous Cell CarcinomaPhase 3NCT06601335
Jan 2027AlconApraclonidine Ophthalmic Solution, 0.125% Unit Dose Preser…Ocular HyperemiaPhase 3NCT07578363
Jan 2027BiocadBCD-217, anti-PD1, Excision of the primary lesion and 1 moreMelanoma Stage III, Melanoma (Skin)Phase 3NCT05751928
Jan 2027Sino Biopharmaceutical LimitedTQB2102 for Injection, Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclita…Breast CancerPhase 3NCT06561607
Jan 2027Sino Biopharmaceutical LimitedAL2846 CapsulesThyroid CancerPhase 3NCT06860971
Jan 2027Colgate-Palmolive Company0.45% SnF HW with NaF (1450 F), 67% Bicarbonate with NaF (1400 F), Colgate Cavity Protection ToothpastePlaque, Dental Plaque and 1 morePhase 3NCT07842991
Jan 2027EmsOMA102Female Pattern BaldnessPhase 3NCT05824065
Jan 2027Hyundai BioscienceCP-COV03DenguePhase 2/3NCT07576868
Jan 2027Lexicon PharmaceuticalsSotagliflozinObstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic CardiomyopathyPhase 3NCT06481891
Jan 2027Praxis Precision Medicines, Inc.40 mg/day vormatrogine for 12 weeks, 30 mg/day vormatrogine for 12 weeks, 20 mg/day vormatrogine for 12 weeksFocal EpilepsyPhase 3NCT07505004
Jan 2027QED Therapeutics, a BridgeBio companyinfigratinib 0.128 mg/kg/day, infigratinib 0.25 mg/kg/dayHypochondroplasiaPhase 2/3NCT06873035
Jan 2027Qilu Pharmaceutical Co., Ltd.QL1206, Prolia®Postmenopausal Women With Osteoporosis at High Risk of FracturePhase 3NCT07062978
Jan 2027Reistone Biopharma Company LimitedRSS0393 ointment 0.03%Plaque Psoriasis SubjectsPhase 3NCT07543224
Jan 2027ResilienceResilience PROCancerPhase 3NCT06867705
Jan 2027Shanghai Huilun Pharmaceutical Co., Ltd.H077 sustained-release tablet, Silodosin capsules Control GroupBenign Prostatic Hyperplasia, Benign Prostatic Hyperplasia With Lower Urinary Tract SymptomsPhase 3NCT07146386
Jan 2027Sinovac Biotechexperimental vaccine, Active Comparator vaccineEpidemic Meningitis, Meningococcal VaccinesPhase 3NCT07505836
Jan 2027Sun PharmaceuticalReformulated Levulan Kerastick containing aminolevulinic a…, Blue Light Photodynamic Therapy Illuminator device, BLU-U®…Actinic KeratosisPhase 3NCT07144852
Jan 2027Sun PharmaceuticalReformulated Levulan Kerastick containing aminolevulinic a…, Blue Light Photodynamic Therapy Illuminator device, BLU-U®…Actinic KeratosisPhase 3NCT07144345
Jan 2027Telix Pharmaceuticals Limited68Ga-PSMA-11PCA, Prostate Cancer and 7 morePhase 3NCT07052214
Jan 2027Ultragenyx Pharmaceutical Inc.setrusumabOsteogenesis ImperfectaPhase 3NCT06636071
Jan 2027Vantive Health LLCPrismocitrate 18, PrisMax System Version 3.x with calcium line accessoryRegional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) and 1 morePhase 3NCT05399537
Jan 2027Xenon PharmaceuticalsAzetukalnerMajor Depressive DisorderPhase 3NCT06922110
Jan 4, 2027AstraZenecaAZD0780Heterozygous Familial HypercholesterolaemiaPhase 3NCT07000136
Jan 4, 2027Merck & Co.Sacituzumab tirumotecan, Trifluridine-Tipiracil, Irinotecan and 4 moreGastroesophageal CancerPhase 3NCT06356311
Jan 4, 2027MoonLake ImmunotherapeuticsSonelokimab, RisankizumabArthritis, PsoriaticPhase 3NCT06641089
Jan 5, 2027Shanghai Mabgeek Biotech.Co.LtdMG-K10 Injection (Humanized Monoclonal Antibody)Dermatitis, AtopicPhase 3NCT07540442
Jan 6, 2027AstraZenecaAnifrolumab (blinded), Anifrolumab (unblinded, open label)Systemic Sclerosis, SclerodermaPhase 3NCT05925803
Jan 6, 2027NorginePLENVU®, Sodium picosulfateBowel Cleansing Prior to Clinical ProceduresPhase 3NCT07218523
Jan 7, 2027SanofiPCV21, 20vPCVSickle Cell DiseasePhase 3NCT07247188
Jan 8, 2027Ocular Therapeutix, IncOTX-TKI, AfliberceptNeovascular Age-related Macular DegenerationPhase 3NCT06495918
Jan 9, 2027GeneQuantum Healthcare (Suzhou) Co., Ltd.GQ1005, T-DM1HER2-positive Breast CancerPhase 3NCT07673029
Jan 10, 2027Bristol-Myers Squibbmezigdomide, Pomalidomide, Bortezomib and 1 moreRelapsed or Refractory Multiple MyelomaPhase 3NCT05519085
Jan 11, 2027AstraZenecaAZD0780Cardiovascular DiseasePhase 3NCT07000123
Jan 11, 2027AstraZenecaDato-DXd, Osimertinib, Pemetrexed and 2 moreMetastatic Non-small Cell Lung CancerPhase 3NCT06417814
Jan 11, 2027FutureGen Biopharmaceutical (Beijing) Co., LtdM108 monoclonal antibody, Oxaliplatin, CapecitabineLocally Advanced Unresectable or Metastatic Gastric Cancer, Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaPhase 3NCT06177041
Jan 12, 2027Merck & Co.Sacituzumab Govitecan, PembrolizumabCarcinoma, Non-Small-Cell LungPhase 3NCT05609968
Jan 13, 2027AkesoAK112, Oxaliplatin, Irinotecan and 2 moreColorectal AdenocarcinomaPhase 3NCT06951503
Jan 13, 2027AstraZenecaTezepelumabChronic Rhinosinusitis With Nasal PolypsPhase 3NCT06706817
Jan 13, 2027iVascular S.L.U.Angiolite: Sirolimus-eluting stent, Xience: Everolimus-eluting stent, 1-month DAPTCoronary Artery DiseasePhase 3NCT05952206
Jan 14, 2027Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.608 doseAnkylosing SpondylitisPhase 3NCT07261644
Jan 15, 2027Sanofiefanesoctocog alfa (BIVV001)Hemophilia APhase 3NCT04644575
Jan 15, 2027IDEAYA BiosciencesIDE196, Crizotinib, Pembrolizumab and 3 moreMetastatic Uveal MelanomaPhase 2/3NCT05987332
Jan 15, 2027Merck & Co.9vHPV VaccinePapillomavirus InfectionsPhase 3NCT04199689
Jan 18, 2027PfizerRSVpreFLower Respiratory Tract IllnessPhase 3NCT05035212
Jan 18, 2027Takeda Pharmaceutical CompanyMaribavirCytomegalovirus (CMV)Phase 3NCT05319353
Jan 20, 2027Turn Therapeutics Inc.GX-03Eczema Atopic Dermatitis, Eczema and 1 morePhase 2/3NCT07355075
Jan 21, 2027AmgenMaridebart CafraglutideObesityPhase 3NCT06858839
Jan 21, 2027AmgenMaridebart cafraglutideType 2 Diabetes Mellitus (T2DM), Obesity, OverweightPhase 3NCT06858878
Jan 21, 2027TG TherapeuticsUblituximabRelapsing Multiple SclerosisPhase 3NCT05877963
Jan 22, 2027Lupin Ltd.Granular powder in unit dose foil-lined sachet Mexiletine …, Oral Capsule Mexiletine (IR)MyotoniaPhase 3NCT07097701
Jan 25, 2027Biotheus Inc.PM8002, Paclitaxel, TopotecanSCLCPhase 3NCT06616532
Jan 25, 2027NovoInsulin icodec, Insulin glargine, Insulin aspartDiabetes Mellitus, Type 1Phase 3NCT07076199
Jan 25, 2027PfizerRSVpreFRespiratory Syncytial Virus (RSV)Phase 3NCT07653100
Jan 25, 2027Vertex PharmaceuticalsSuzetrigineDiabetic Peripheral Neuropathic PainPhase 3NCT06696443
Jan 26, 2027GSKFF/UMEC/VI, ELLIPTA, FF/VIAsthmaPhase 3NCT05757102
Jan 28, 2027ModernamRNA-1018-H5InfluenzaPhase 3NCT07496450
Jan 28, 2027NovartisAlpelisib, FulvestrantBreast CancerPhase 3NCT05038735
Jan 29, 2027NovartisiptacopanC3GPhase 3NCT04817618
Jan 29, 2027NovoZiltivekimabCardiovascular Risk, Acute Myocardial Infarction (AMI)Phase 3NCT06118281
Jan 29, 2027Pfizerdisitamab vedotin, pembrolizumab, gemcitabine and 2 moreUrothelial CarcinomaPhase 3NCT05911295
Jan 30, 2027Roche HoldingAfimkibartModerately to Severely Active Ulcerative ColitisPhase 3NCT06589986
Jan 30, 2027Shanghai Runshi Pharmaceutical Technology Co., Ltdsimmitinib, investigator's choice of chemotherapy,include docetaxel or…Advanced Oesophageal Squamous Cell CarcinomaPhase 3NCT06656091
Jan 30, 2027Sinovac BiotechRabies vaccine, Verorab®Rabies (Healthy Volunteers)Phase 3NCT07055893
Jan 31, 2027Johnson & JohnsonMacitentan, Selexipag, Macitentan/Tadalafil FDCHypertension, PulmonaryPhase 3NCT05179876
Jan 31, 2027Merck & Co.Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy (Bladder and pelvic nodes) and 5 moreUrinary Bladder NeoplasmsPhase 3NCT04241185
Jan 31, 2027Ono PharmaceuticalCenobamateEpilepsy, GeneralizedPhase 3NCT06579573
Jan 31, 2027Quoin Pharmaceuticals Ltd.QRX003Netherton SyndromePhase 2/3NCT07538583
Jan 31, 2027Tiohundra ABVasopressin; Methylprednisolone; Hydrocortisone, Sodium chlorideCardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical TrialPhase 3NCT05139849
Jan 31, 2027iRenix Medical, Inc.IRX-101, Providone-IodineRetinal DiseasePhase 3NCT05750589

93 phase 2 readouts too. All 166 phase 2 and 3 readouts in Jan 2027

February 2027

Phase 3 readouts: 46

Primary completionSponsorDrugConditionPhaseRecord
Feb 2027AlconApraclonidine Ophthalmic Solution, 0.125% Unit Dose Preser…Ocular HyperemiaPhase 3NCT07531043
Feb 2027CelltrionCT-P51, EU-approved KeytrudaNon Squamous Non Small Cell Lung CancerPhase 3NCT06939595
Feb 2027CelltrionCT-P53, US-Ocrevus, EU-OcrevusRelapsing-remitting Multiple SclerosisPhase 3NCT05906992
Feb 2027Sino Biopharmaceutical LimitedTQC3721 Suspension for InhalationChronic Obstructive Pulmonary DiseasePhase 3NCT07464587
Feb 2027EmsDEH113Primary DysmenorrheaPhase 3NCT06268054
Feb 2027Eli Lilly and CompanyOrforglipronObesity, OverweightPhase 3NCT06672549
Feb 2027Eurofarma Laboratorios S.A.Experimental drugAcne Vulgaris, Acne Vulgaris on the FacePhase 3NCT06905210
Feb 2027Fujian Shengdi Pharmaceutical Co., Ltd.HRS9531Type 2 DiabetesPhase 3NCT07060456
Feb 2027Gilead SciencesSacituzumab Govitecan-hziy, Pembrolizumab, Paclitaxel and 3 moreTriple Negative Breast Cancer, PD-L1 PositivePhase 3NCT05382286
Feb 2027Hangzhou Gensciences Biopharmaceutical Co., Ltd.FRSW107Severe Hemophilia APhase 3NCT07663903
Feb 2027Kallyope Inc.ElismetrepMigrainePhase 3NCT07645924
Feb 2027Keymed Biosciences Co.LtdStapokibatrtAtopic DermatitisPhase 3NCT07106372
Feb 2027Kodiak Sciences Inc.KSI-101, Sham ComparatorMacular Edema Secondary to InflammationPhase 3NCT06996080
Feb 2027Otsuka PharmaceuticalOPA-15406Atopic Dermatitis (AD)Phase 3NCT07184645
Feb 2027PT Bio FarmaIn-house Hepatitis B Vaccine, Registered Hepatitis B VaccineVaccination Adverse Event, Immunogenicity, VaccinePhase 3NCT07854847
Feb 2027SK Life Science, Inc.CarisbamateSeizures, Lennox Gastaut SyndromePhase 3NCT05219617
Feb 2027Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.610AsthmaPhase 3NCT06323213
Feb 2027Trust Bio-sonics, Inc.NH002 (Perflutren Lipid Microspheres) Injectable SuspensionCardiac DiseasesPhase 3NCT06815627
Feb 2, 2027Noema Pharma AGBasimglurantTrigeminal NeuralgiaPhase 2/3NCT05217628
Feb 4, 2027Roche HoldingRanibizumab, Port Delivery System with RanibizumabNeovascular Age-related Macular Degeneration (nAMD)Phase 3NCT04657289
Feb 10, 2027Johnson & JohnsonIcotrokinraArthritis, PsoriaticPhase 3NCT06807424
Feb 10, 2027Johnson & JohnsonGuselkumab Subcutaneous, Guselkumab IntravenousColitis, UlcerativePhase 3NCT06260163
Feb 10, 2027Takeda Pharmaceutical CompanyTeduglutideShort Bowel SyndromePhase 3NCT06973304
Feb 11, 2027NovartisInclisiranAcute Coronary SyndromePhase 3NCT07102628
Feb 12, 2027OcugenSub-Retinal Administration of OCU400-301Retinitis PigmentosaPhase 3NCT06388200
Feb 13, 2027Epizyme, Inc.Tazemetostat, Lenalidomide, RituximabRelapsed/Refractory Follicular Lymphoma, Follicular Lymphoma and 1 morePhase 3NCT04224493
Feb 13, 2027SK Bioscience Co., Ltd.NBP608 (Mid Potency), NBP608 (Low Potency), Varivax® and 1 moreVaricella (Chickenpox)Phase 3NCT07415252
Feb 14, 2027Hudson BiotechTirzepatide, Reduced-calorie dietObesity, Overweight (Without Type 2 Diabetes) With Weight-related ComorbiditiesPhase 3NCT07481747
Feb 15, 2027Acerta PharmaAcalabrutinib, Bendamustine, RituximabLymphoma, Mantle CellPhase 3NCT02972840
Feb 15, 2027CanSino BiologicsPCV13i, Prevnar 13Pneumococcal Infections, Streptococcal Infections and 1 morePhase 3NCT07017777
Feb 15, 2027ModernamRNA-1403Acute Gastroenteritis, Norovirus Acute GastroenteritisPhase 3NCT06592794
Feb 16, 2027Bristol-Myers SquibbRepotrectinib, CrizotinibCarcinoma, Non-Small-Cell LungPhase 3NCT06140836
Feb 16, 2027Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg and 1 moreType 2 DiabetesPhase 3NCT07082114
Feb 17, 2027SanofiItepekimab (SAR440340)Chronic Rhinosinusitis With Nasal PolypsPhase 3NCT07424144
Feb 18, 2027AstraZenecaZibotentan/Dapagliflozin, DapagliflozinChronic Kidney Disease With High ProteinuriaPhase 3NCT06087835
Feb 19, 2027Xuanzhu Biopharmaceutical Co., Ltd.Anaprazole Sodium enteric-coated tablet, Esomeprazole magnesium enteric-coated tabletsHELICOBACTER PYLORI INFECTIONSPhase 3NCT07606833
Feb 20, 2027Regeneron PharmaceuticalsREGN7508, Apixaban, EnoxaparinVenous Thromboembolism (VTE)Phase 3NCT07015905
Feb 22, 2027Acerta Pharmaacalabrutinib, Prednisone, Rituximab and 3 moreDiffuse Large B-Cell LymphomaPhase 3NCT04529772
Feb 22, 2027AstraZenecaOsimertinibCancerPhase 3NCT05629234
Feb 22, 2027NovartisRemibrutinib, DupilumabChronic Spontaneous Urticaria (CSU)Phase 3NCT06868212
Feb 23, 2027AstraZenecaAnifrolumabLupus NephritisPhase 3NCT05138133
Feb 25, 2027GSKHFA-152a, HFA-134aAsthmaPhase 3NCT07645248
Feb 26, 2027ArdelyxTenapanor 5 mg BID, Tenapanor 25 mg BID, Tenapanor 50 mg BIDChronic Idiopathic Constipation (CIC)Phase 3NCT07382167
Feb 26, 2027NovartisAlpelisib, Trastuzumab, PertuzumabAdvanced HER2+Breast CancerPhase 3NCT04208178
Feb 28, 2027Innovent BiologicsAflibercept Ophthalmic, IBI302Neovascular Age-related Macular DegenerationPhase 3NCT05972473
Feb 28, 2027Institut Pasteur–Hidradenitis SuppurativaPhase 3NCT05821478

119 phase 2 readouts too. All 165 phase 2 and 3 readouts in Feb 2027

March 2027

Phase 3 readouts: 76

Primary completionSponsorDrugConditionPhaseRecord
Mar 2027ABX advanced biochemical compounds GmbH[18F]PSMA-1007Prostate CancerPhase 3NCT06122584
Mar 2027AFT Pharmaceuticals, Ltd.Combogesic® IV (fixed-dose combination containing acetamin…Acute PainPhase 3NCT07225634
Mar 2027AbbVieCariprazineDepression, Bipolar I DisorderPhase 3NCT04777357
Mar 2027AbbVieRisankizumab SCCrohn's DiseasePhase 3NCT06063967
Mar 2027AbbVieUpadacitinibSystemic Lupus ErythematosusPhase 3NCT05843643
Mar 2027Ache Laboratorios Farmaceuticos S.A.Product DNN.63.18.040, Tramal®Acute PainPhase 3NCT07880392
Mar 2027Amicus TherapeuticsCipaglucosidase Alfa, MiglustatPompe Disease (Late-onset)Phase 3NCT03911505
Mar 2027Jiangsu Hengrui Medicine–HypertriglyceridemiaPhase 3NCT07349615
Mar 2027BlueRock Therapeuticsbemdaneprocel, Sham surgeryParkinsons Disease (PD)Phase 3NCT06944522
Mar 2027Sino Biopharmaceutical LimitedTQB3473 TabletsPrimary Immune ThrombocytopeniaPhase 3NCT06900920
Mar 2027Sino Biopharmaceutical LimitedTQC3721 Suspension for inhalationChronic Obstructive Pulmonary DiseasePhase 3NCT07147946
Mar 2027Dompé Farmaceutici S.p.ADFL24498, dexamethasone sodium phosphate (DSP) ophthalmic solutionAtopic KeratoconjunctivitisPhase 3NCT07395232
Mar 2027Fujian Shengdi Pharmaceutical Co., Ltd.HRS9531 injection, Semaglutide InjectionObesityPhase 3NCT07285902
Mar 2027Grace Science, LLCGS-100NGLY1 DeficiencyPhase 3NCT06199531
Mar 2027Ionis Pharmaceuticals IncOlezarsenSevere HypertriglyceridemiaPhase 3NCT05681351
Mar 2027Jiangsu Hengrui MedicineRezvilutamide Tablets, Enzalutamide Soft CapsulesMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Phase 3NCT07241416
Mar 2027Madrigal Pharmaceuticals, INC.ResmetiromNon-Alcoholic Fatty Liver DiseasePhase 3NCT04951219
Mar 2027MegalabsExperimental: Epoetin alfa Megalabs® Erythropoietin inject…, Active comparator: European Union licenced epoetin alfaAnemia of Chronic Kidney DiseasePhase 3NCT06352138
Mar 2027Merz TherapeuticsXeominChronic MigrainePhase 3NCT07018713
Mar 2027Merz TherapeuticsXeominEpisodic MigrainePhase 3NCT07018700
Mar 2027Ocular Therapeutix, IncSingle intravitreal injection of axitinib hydrogel implant…, Intravitreal injection of axitinib hydrogel implant follow…, Sham/mock procedure of intravitreal injection followed by …Non-Proliferative Diabetic RetinopathyPhase 3NCT07235085
Mar 2027Qilu Pharmaceutical Co., Ltd.1.5% QLM3003 ointment, 2% QLM3003 ointmentAtopic DermatitisPhase 3NCT06880276
Mar 2027Quetzal TherapeuticsQTX-2101 + ATRA, IV arsenic trioxide (ATO) + ATRAAcute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia and 3 morePhase 3NCT07504458
Mar 2027Seattle Project CorporationGRT-C901, GRT-R902, Atezolizumab and 3 moreColorectal NeoplasmsPhase 2/3NCT05141721
Mar 2027Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.TQC2731 injectionChronic Rhinosinusitis With Nasal Polyps (CRSwNP)Phase 3NCT07107256
Mar 2027Sinovac BiotechSinovac PCV13 lot 1, Sinovac PCV13 lot 2, Sinovac PCV13 lot 3Pneumococcal Infectious DiseasesPhase 3NCT07832500
Mar 2027Stoke Therapeutics, Inc.zorevunersen, Sham ComparatorDravet SyndromePhase 3NCT06872125
Mar 2027Jiangsu Hengrui MedicineSHR-A1912 Injection, Rituximab Injection, Gemcitabine Hydrochloride for Injection and 1 moreDiffuse Large B-cell LymphomaPhase 3NCT06929624
Mar 2027Swedish Orphan BiovitrumEfanesoctocog alfaHaemophilia A (Moderate or Severe)Phase 3NCT06716814
Mar 2027UroGen Pharma Ltd.UGN-104Upper Urinary Tract Urothelial Carcinoma, Urothelial CarcinomaPhase 3NCT06774131
Mar 2027Vaxcyte, Inc.31-valent pneumococcal conjugate vaccine, PCV20Pneumococcal VaccinesPhase 3NCT07425392
Mar 2027Vaxcyte, Inc.31-valent pneumococcal conjugate vaccine, Seasonal Influenza Vaccine (SIV) (Flublok)Pneumococcal VaccinesPhase 3NCT07365826
Mar 2027Vor Biopharma Inc.TelitaciceptGeneralized Myasthenia GravisPhase 3NCT06456580
Mar 2027Argenx SEEfgartigimod IVGeneralized Myasthenia GravisPhase 2/3NCT04833894
Mar 1, 2027Aragon Pharmaceuticals, Inc.Apalutamide, Bicalutamide, GnRH (agonist) and 1 moreProstatic NeoplasmsPhase 3NCT02531516
Mar 1, 2027EyeBiotech Ltd.Remigromig, RanibizumabDiabetic Macular Edema (DME)Phase 2/3NCT06957080
Mar 1, 2027GSKDepemokimabAsthmaPhase 3NCT07671001
Mar 1, 2027NovoCagriSema (Cagrilintide B and Semaglutide I)ObesityPhase 3NCT07011667
Mar 1, 2027Smilebiotek Zhuhai LimitedQA108 granulesIntermediate Age-Related Macular DegenerationPhase 3NCT07189169
Mar 1, 2027Zero Point Five TherapeuticsZP5-9676 600 mg doseSoil-Transmitted Helminthiasis (STH)Phase 3NCT06128447
Mar 7, 2027Hansoh Pharmaceutical GroupHS-20089, Paclitaxel, Doxorubicin and 1 moreOvarian CancerPhase 3NCT06855069
Mar 8, 2027CelltrionCT-P44(Daratumumab), Darzalex Faspro(Daratumumab)Refractory or Relapsed Multiple MyelomaPhase 3NCT06952478
Mar 9, 2027Hangzhou Gensciences Biopharmaceutical Co., Ltd.FRSW107Severe Hemophilia APhase 3NCT07684898
Mar 9, 2027UCBbimekizumabModerate to Severe Plaque Psoriasis, Psoriatic ArthritisPhase 3NCT06506916
Mar 11, 2027Bristol-Myers SquibbNivolumab, IpilimumabRenal Cell CarcinomaPhase 3NCT03873402
Mar 13, 2027Rhythm Pharmaceuticals, Inc.SetmelanotideHypothalamic Obesity, Multiple Pituitary Hormone Deficiency Genetic Form and 4 morePhase 3NCT06760546
Mar 14, 2027Zai Lab (Shanghai) Co., Ltd.ZL-1109 (VRDN-003)Thyroid Eye Disease (TED)Phase 3NCT07211776
Mar 16, 2027Takeda Pharmaceutical CompanyTAK-755Thrombotic Thrombocytopenic Purpura (TTP)Phase 3NCT04683003
Mar 17, 2027PfizertofacitinibUlcerative ColitisPhase 3NCT04624230
Mar 19, 2027Applied Biology, Inc.DA-001, Phenylephrine, DA-001 Topical + DA-005 Oral (HIF-1α supplement) and 3 moreTelogen Effluvium, Female Pattern Hair Loss and 4 morePhase 2/3NCT06648850
Mar 22, 2027Regeneron Pharmaceuticalsfianlimab, cemiplimab, relatlimab+nivolumabMelanomaPhase 3NCT06246916
Mar 25, 2027Johnson & JohnsonGuselkumabFistulizing Crohns Disease, Perianal Crohns DiseasePhase 3NCT05347095
Mar 25, 2027SanofiFitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate (ATIIIC)HemophiliaPhase 3NCT05662319
Mar 26, 2027LundbeckEptinezumabChronic Migraine in ChildrenPhase 3NCT04965675
Mar 26, 2027NovartisIanalumabSystemic Lupus ErythematosusPhase 3NCT05639114
Mar 26, 2027Shanghai JMT-Bio Inc.JMT101 Injection, Osimertinib tablet, Cisplatin injection and 1 moreLocal Advanced or Metastatic NSCLCPhase 3NCT06380348
Mar 28, 2027Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.quadrivalent recombinant norovirus vaccine (Pichia pastoris)Acute Gastroenteropathy Due to NorovirusPhase 3NCT06524947
Mar 30, 2027Hansoh Pharmaceutical GroupHS-20094 Injection, Dulaglutide InjectionType 2 DiabetesPhase 3NCT07156539
Mar 30, 2027Hansoh Pharmaceutical GroupHS-20094 InjectionType 2 DiabetesPhase 3NCT07156500
Mar 30, 2027Shin Poong Pharmaceutical Co. Ltd.SP-8203Ischemic StrokePhase 3NCT06660719
Mar 31, 2027Ascentage Pharma Group InternationalOlverembatinibGISTPhase 3NCT06640361
Mar 31, 2027Hangzhou Sumgen Biotech Co., Ltd.SG301 Injection, pomalidomide, dexamethasoneRelapsed/Refractory Multiple MyelomaPhase 3NCT06508983
Mar 31, 2027Hansoh Pharmaceutical GroupHS-20137Moderate-to-severe Plaque PsoriasisPhase 3NCT06844799
Mar 31, 2027Roche HoldingAtezolizumab, Trastuzumab Emtansine, TrastuzumabBreast CancerPhase 3NCT04873362
Mar 31, 2027Roche HoldingSatralizumabNeuromyelitis Optica Spectrum Disorder, NMOSDPhase 3NCT05199688
Mar 31, 2027Kissei PharmaceuticalKPS-0373Spinocerebellar DegenerationPhase 3NCT07040137
Mar 31, 2027Natureceuticals Sdn BhdNuvastatic™Fatigue, Colon CancerPhase 3NCT07669519
Mar 31, 2027Neuraptive Therapeutics Inc.NTX-001 (PEG-Fusion)Peripheral Nerve Injury Upper Limb, Peripheral Nerve Injury (PNI)Phase 3NCT06616025
Mar 31, 2027Newron Pharmaceuticals SPAEvenamide 15 mg bidTreatment-resistant SchizophreniaPhase 3NCT07184619
Mar 31, 2027NovartisCTL019B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell LymphomaPhase 3NCT04094311
Mar 31, 2027PfizerRitlecitinib, Ritlecitinib 100 mgVitiligoPhase 3NCT06163326
Mar 31, 2027Pierre Fabre MedicamentEncorafenib and BinimetinibMelanomaPhase 3NCT05270044
Mar 31, 2027Regenerative Ocular Immunobiologics LLCd-MAPPS™ Ophthalmic Solution, Matching vehicle controloGVHD, Ocular Graft Versus Host DiseasePhase 3NCT07776210
Mar 31, 2027Sinovac BiotechSNA02-48, Human tetanus immunoglobulin (HTIG)TetanusPhase 3NCT07633119
Mar 31, 2027TuHURA Biosciences, Inc./NVIFx-Hu2.0, PembrolizumabAdvanced Or Metastatic Merkel Cell CarcinomaPhase 2/3NCT06947928
Mar 31, 2027ViatrisCenerimodLupus Erythematosus, SystemicPhase 3NCT05648500

155 phase 2 readouts too. All 231 phase 2 and 3 readouts in Mar 2027

April 2027

Phase 3 readouts: 66

Primary completionSponsorDrugConditionPhaseRecord
Apr 2027AbbVieMirvetuximab soravtansine plus Bevacizumab, BevacizumabOvarian Cancer, Peritoneal Cancer and 1 morePhase 3NCT05445778
Apr 2027Ache Laboratorios Farmaceuticos S.A.Product DNN.65.21.005, Combodart®Prostatic Hyperplasia, BenignPhase 3NCT07270432
Apr 2027Beijing Kanghong Biological Medicine Co., Ltd.KHN939Thyroid Eye DiseasePhase 3NCT07720635
Apr 2027BiocadANB-002Hemophilia BPhase 3NCT06700096
Apr 2027Colgate-Palmolive CompanySilica Free Meridol, Meridol, Colgate Dental ProductGingivitisPhase 3NCT07842978
Apr 2027Coya Therapeutics, Inc.COYA 302Amyotrophic Lateral Sclerosis (ALS)Phase 2/3NCT07161999
Apr 2027EpygenixClemizole HClDravet SyndromePhase 3NCT04462770
Apr 2027Harmony Biosciences Management, Inc.Pitolisant tabletPrader-Willi SyndromePhase 3NCT06366464
Apr 2027Jiangsu Genscend Biopharmaceutical Co., LtdGS101 injection, DUPIXENT®Atopic Dermatitis (AD)Phase 3NCT07386743
Apr 2027Kodiak Sciences Inc.KSI-101, Sham ComparatorMacular Edema Secondary to InflammationPhase 3NCT06990399
Apr 2027LeonaBio, Inc.Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclibMetastatic Breast CancerPhase 3NCT05696626
Apr 2027Medicinova IncMN-166Amyotrophic Lateral SclerosisPhase 2/3NCT04057898
Apr 2027RHEACELL GmbH & Co. KGallo-APZ2-CVUVenous Leg UlcerPhase 3NCT06489028
Apr 2027Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SKB264, Paclitaxel, Nab-paclitaxel and 3 moreTriple Negative Breast CancerPhase 3NCT06279364
Apr 2027Sinovac Biotechexperimental vaccine, Active Comparator vaccineEpidemic Meningitis, Meningococcal VaccinesPhase 3NCT07505823
Apr 2027Sinovac Biotechexperimental vaccine, Active Comparator vaccineEpidemic Meningitis, Meningococcal VaccinesPhase 3NCT07505810
Apr 2027Taiho Oncology, Inc.futibatinib, futibatinib, fulvestrantAdvanced/Metastatic CancerPhase 2/3NCT06506955
Apr 2027Xenon PharmaceuticalsXEN1101Primary Generalized Tonic-Clonic SeizuresPhase 3NCT05667142
Apr 2027mAbxience Research S.L.MB11 (Proposed Nivolumab Biosimilar), EU-Opdivo®, US- sourced Opdivo®Advanced (Unresectable or Metastatic) MelanomaPhase 3NCT07221734
Apr 2027vTv Therapeutics Inc.Cadisegliatin 800 mg QD, Cadisegliatin 800 mg BIDDiabetes Mellitus, Type 1Phase 3NCT06334133
Apr 1, 2027Cerium Pharmaceuticals, Inc.SNP-ACTH (1-39) Gel, RituximabPrimary Membranous NephropathyPhase 3NCT05696613
Apr 1, 2027Jiangsu Famous Medical Technology Co., Ltd.XLJDOD compound granuleColon CancerPhase 3NCT05709249
Apr 1, 2027Jiankuan (Suzhou) Biotechnology Company LimitedProximodRheumatoid ArthritsPhase 3NCT07856511
Apr 1, 2027Kaneka Americas Holding Inc.Lactobacillus gasseri KABP®064 10e9 CFU/capsuleVaginosis, Bacterial, Bacterial Vaginosis and 1 morePhase 2/3NCT07527572
Apr 1, 2027Shenzhen Sciencare Medical Industries Co., Ltd.NaltrexoneAlcohol Use Disorder (AUD)Phase 3NCT07433413
Apr 1, 2027Taejoon Pharmaceutical Co., Ltd.CTO0308MyopiaPhase 3NCT07790640
Apr 5, 2027Intra-Cellular Therapies, Inc.LumateperoneMajor Depressive DisorderPhase 3NCT05850689
Apr 5, 2027SanofiIsatuximab SAR650984, Bortezomib, Lenalidomide and 1 morePlasma Cell MyelomaPhase 3NCT03319667
Apr 6, 2027AstraZenecaOlaparibOvarian Cancer, Breast CancerPhase 3NCT04421963
Apr 6, 2027Csl LtdBE1116, FFPComplex Cardiovascular Surgery With Cardiopulmonary BypassPhase 3NCT07094087
Apr 6, 2027Vertex PharmaceuticalsELX/TEZ/IVA, IVACystic FibrosisPhase 3NCT05331183
Apr 6, 2027Vertex PharmaceuticalsSuzetrigineDiabetic Peripheral Neuropathic PainPhase 3NCT07231419
Apr 9, 2027R-Pharm International, LLCSubcutaneous (SC) injections of OKZ 64 milligrams (mg) eve…Lung Diseases, InterstitialPhase 2/3NCT06440746
Apr 9, 2027Shanghai Henlius BiotechHLX17, US-sourced Keytruda®, EU-sourced Keytruda®Non-Squamous Non-Small Cell Lung CancerPhase 3NCT06847334
Apr 10, 2027BayerFinerenone (Kerendia, BAY94-8862)Chronic Kidney Disease, ProteinuriaPhase 3NCT05196035
Apr 12, 2027NovartisianalumabSystemic Lupus ErythematosusPhase 3NCT05624749
Apr 14, 2027Takeda Pharmaceutical CompanyTDVDengue FeverPhase 3NCT06579755
Apr 15, 2027Boehringer IngelheimNerandomilastInterstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung DiseasesPhase 3NCT06806592
Apr 16, 2027AstraZeneca–Heart Failure and Impaired Kidney FunctionPhase 3NCT06307652
Apr 16, 2027Boehringer IngelheimEmpagliflozinChronic Kidney DiseasePhase 3NCT07107945
Apr 16, 2027Staidson (Beijing) Biopharmaceuticals Co., LtdBDB-001 injection, Cyclophosphamide, Rituximab and 2 moreANCA Associated Vasculitis (AAV)Phase 3NCT07168161
Apr 18, 2027Roche HoldingCrovalimab, EculizumabParoxysmal Nocturnal HemoglobinuriaPhase 3NCT04432584
Apr 18, 2027Zydus Therapeutics Inc.Saroglitazar Magnesium 1 mgPrimary Biliary CholangitisPhase 3NCT06427395
Apr 19, 2027AmgenOcrelizumab (US), Ocrelizumab (EU), ABP 692Relapsing-remitting Multiple Sclerosis (RRMS)Phase 3NCT06700343
Apr 20, 2027AstraZenecaCamizestrant, Tamoxifen, Anastrozole and 2 moreBreast Cancer, Early Breast CancerPhase 3NCT05774951
Apr 21, 2027BioNTechBNT162b2COVID-19 VaccinesPhase 3NCT07798648
Apr 25, 2027Almirall, S.A.LebrikizumabDermatitis, Atopic, EczemaPhase 3NCT06526182
Apr 25, 2027Oramed PharmaceuticalsORMD-0801 8 mg, ORMD-0801 16 mgType 2 Diabetes MellitusPhase 3NCT06731075
Apr 27, 2027AmgenMaridebart cafraglutideObesity DiseasePhase 3NCT06987695
Apr 28, 2027Boehringer IngelheimNerandomilastIdiopathic Pulmonary Fibrosis, Progressive Pulmonary FibrosisPhase 3NCT06238622
Apr 28, 2027CSPC Pharmaceutical GroupSYHX1901Moderate to Severe Plaque PsoriasisPhase 3NCT06943950
Apr 30, 2027Acerta PharmaAcalabrutinib, Venetoclax, Chemoimmunotherapy and 1 moreChronic Lymphocytic LeukemiaPhase 3NCT03836261
Apr 30, 2027Bio-Thera SolutionsBAT5906 injection, LucentisDiabetic Macular Edema (DME)Phase 3NCT07515079
Apr 30, 2027BrightGene Bio-Medical Technology Co.BGM0504, SemaglutideType 2 Diabetes (T2DM)Phase 3NCT07064486
Apr 30, 2027Grand Theravac Life Sciences (Nanjing) Co., Ltd.TVAV-008, PegIFNα2b, PlacebChronic hepatitisBPhase 3NCT07282249
Apr 30, 2027Roche HoldingBaloxavir marboxilInfluenza, Human, Respiratory Tract Infections and 1 morePhase 3NCT07827599
Apr 30, 2027Roche HoldingEmicizumab, von Willebrand Factor (VWF) Concentrates, Factor VIII (FVIII) Concentrates and 2 moreVon Willebrand Disease, Type 3Phase 3NCT06998524
Apr 30, 2027IncyteRuxolitinib CreamNonSegmental VitiligoPhase 3NCT06804811
Apr 30, 2027Innovent BiologicsFebuxostat, TigulixostatGoutPhase 3NCT07414394
Apr 30, 2027Intuitive SurgicalfilricianineUreter InjuryPhase 3NCT07346066
Apr 30, 2027JYAMS PET Research & Development Limited[18F]-APN-1607Alzheimer's DiseasePhase 3NCT07752784
Apr 30, 2027NovartisIptacopanGeneralized Myasthenia GravisPhase 3NCT06517758
Apr 30, 2027Pharmacosmos A/SFerric DerisomaltoseIron Deficiency, Anaemia in ChildrenPhase 3NCT05179226
Apr 30, 2027Qilu Pharmaceutical Co., Ltd.QL0911Cancer Treatment-Induced ThrombocytopeniaPhase 2/3NCT06456528
Apr 30, 2027Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Luvometinib, Chemotherapeutic Agent COG-V/C Carboplatin + Vindesine, Ca…Low-grade Glioma, Pediatric Low-grade Gliomas and 1 morePhase 3NCT07004075
Apr 30, 2027VivaVision Biotech, IncVVN001 Ophthalmic Solution, 5%, VVN001 Ophthalmic Solution, VehicleDry EyePhase 3NCT06360133

116 phase 2 readouts too. All 182 phase 2 and 3 readouts in Apr 2027

May 2027

Phase 3 readouts: 77

Primary completionSponsorDrugConditionPhaseRecord
May 2027AbbVieUbrogepantMigrainePhase 3NCT05125302
May 2027Aerogen Pharma LimitedAPC-0101 (SF-RI 1 surfactant for inhalation combined with …, ControlRespiratory Distress Syndrome, Pre-term InfantsPhase 3NCT06776783
May 2027AkesoIvonescimab, docetaxelNon-Small Cell Lung CancerPhase 3NCT06928389
May 2027AlkermesALKS 2680 Dose 1, ALKS 2680 Dose 2, ALKS 2680 Dose 3Narcolepsy Type 2Phase 3NCT07502443
May 2027AlkermesALKS 2680 Dose 1, ALKS 2680 Dose 2Narcolepsy Type 1Phase 3NCT07455383
May 2027Barbara MaglioneCLR Tablets - Heparan SulphateChronic Venous Disease, Vein Disease and 1 morePhase 3NCT07684833
May 2027Beijing Kanghong Biological Medicine Co., Ltd.KHN939Thyroid Eye DiseasePhase 3NCT07720648
May 2027Bigespas LTDDMB-I (INN: Latrepirdine), Memantine Hydrochloride 20 MGAlzheimer Type DementiaPhase 3NCT07251023
May 2027Crinetics PharmaceuticalsAtumelnantCongenital Adrenal Hyperplasia, Classic Congenital Adrenal HyperplasiaPhase 3NCT07144163
May 2027Eli Lilly and CompanyOrforglipronDiabetes Mellitus, Type 2, Diabetes Melletus and 14 morePhase 3NCT07613307
May 2027Eli Lilly and CompanyLY3650150, Standard therapy for INCSChronic Rhinosinusitis With Nasal Polyps (CRSwNP)Phase 3NCT06338995
May 2027GRIN Therapeutics, Inc.RadiprodilGRIN-related Neurodevelopmental DisorderPhase 3NCT07224581
May 2027Gameto, Inc.Fertilo, Medicult IVMIn Vitro Maturation of OocytesPhase 3NCT06858111
May 2027Genetix Biotherapeutics Inc.bb1111Sickle Cell DiseasePhase 3NCT04293185
May 2027Huons BiopharmaHU-045, Xeomin®Glabellar LinesPhase 3NCT07870694
May 2027Jiangsu Hengrui MedicineSHR-A1811, Paclitaxel Injection, Doxorubicin Hydrochloride Liposome Injection and 2 moreOvarian CancerPhase 3NCT06828354
May 2027Minoryx Therapeutics, S.L.LeriglitazoneCerebral Adrenoleukodystrophy (cALD)Phase 3NCT05819866
May 2027ViatrisTransdermal system containing progestinFemale ContraceptionPhase 3NCT06672016
May 2027OKYO Pharma LtdUrcosimod ophthalmic solution is a preservative-free topic…Neuropathic Corneal PainPhase 3NCT07838506
May 2027Priothera SASmocravimodAdult Acute Myeloid LeukemiaPhase 3NCT05429632
May 2027Qilu Pharmaceutical Co., Ltd.QLG2128, Teriparatide InjectionPostmenopausal Women With OsteoporosisPhase 3NCT06898060
May 2027Qilu Pharmaceutical Co., Ltd.QL2108 injection, Dupixent®Atopic DermatitisPhase 3NCT06884891
May 2027Qilu Pharmaceutical Co., Ltd.Daprodustat, Darbepoetin alfaAnaemiaPhase 3NCT07300111
May 2027Qilu Pharmaceutical Co., Ltd.MHB088C for Injection, Topotecan, Irinotecan and 1 moreSmall Cell Lung Cancer Extensive StagePhase 3NCT06954246
May 2027Sichuan Baili Pharmaceutical Co., Ltd.BL-M07D1, Capecitabine, Eribulin, Gemcitabine, Paclitaxel, or Albumi…HER2-low Breast CancerPhase 3NCT06957886
May 2027Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SKB264, OsimertinibNon-Small Cell Lung CancerPhase 3NCT06670196
May 2027Skyhawk Therapeutics, Inc.SKY-0515Huntington Disease, Huntingtons DiseasePhase 2/3NCT06873334
May 2027Sun PharmaceuticalCTP-543Alopecia AreataPhase 2/3NCT03898479
May 2027Verrica Pharmaceuticals Inc.VP-102 (US) / TO-208 (Japan)Common Warts, Common Warts (Verruca Vulgaris) and 2 morePhase 3NCT07637734
May 2027Xenon PharmaceuticalsAzetukalnerMajor Depressive DisorderPhase 3NCT07076407
May 1, 2027IntraBio IncN-Acetyl-L-LeucineCACNA1A, Spinocerebellar Ataxia Type 6 and 2 morePhase 3NCT07221292
May 2, 2027PfizerAbrocitinibEczemaPhase 3NCT06807268
May 4, 2027AmgenRomosozumab, BisphosphonateOsteogenesis ImperfectaPhase 3NCT05972551
May 5, 2027Merck & Co.Pembrolizumab, Olaparib, Etoposide and 6 moreLung Neoplasms, Carcinoma, Non-Small-Cell LungPhase 3NCT04380636
May 6, 2027SanofiFrexalimab, Teriflunomide, MRI contrast-enhancing agents and 2 moreMultiple SclerosisPhase 3NCT06141473
May 6, 2027UCBRozanolixizumabMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)Phase 3NCT05063162
May 7, 2027Innovent BiologicsIBI362Sleep Apnea, Obstructive and 1 morePhase 3NCT06931028
May 10, 2027Merck & Co.Sacituzumab tirumotecan, Docetaxel, PemetrexedNon-small Cell Lung Cancer (NSCLC)Phase 3NCT06074588
May 10, 2027NovartisInclisiran sodium 300 mgAtherosclerotic Cardiovascular DiseasePhase 3NCT05030428
May 11, 2027Roche HoldingBaloxavir MarboxilInfluenzaPhase 3NCT06094010
May 11, 2027NovoCagrilintideObesity, OverweightPhase 3NCT07220642
May 12, 2027NovoCagrilintideOverweight, Obesity and 1 morePhase 3NCT07220759
May 12, 2027RemeGen Co., Ltd.RC148 (Dose 1) plus Capecitabine and Oxaliplatin, RC148 (Dose 2) plus Capecitabine and OxaliplatinColorectal (Colon or Rectal) CancerPhase 2/3NCT07462143
May 14, 2027AkesoIvonescimab, AK117, Albumin-bound Paclitaxel, GemcitabinePancreatic CancerPhase 3NCT06953999
May 14, 2027GSKTafenoquine, Primaquine, ChloroquineMalaria, VivaxPhase 3NCT06666491
May 14, 2027Johnson & JohnsonNipocalimabPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingPhase 2/3NCT05327114
May 15, 2027Genrix (Shanghai) Biopharmaceutical Co., Ltd.GR1802 injectionAllergic Rhinitis, SeasonalPhase 3NCT07199257
May 16, 2027PfizerRSVpreFAdult, Healthy ParticipantsPhase 3NCT07819097
May 17, 2027NovartisRemibrutinib Dose A, Remibrutinib Dose BHidradenitis SuppurativaPhase 3NCT06799000
May 17, 2027Paradigm TherapeuticsSD-101 Dermal Cream (6%)Epidermolysis Bullosa (EB)Phase 3NCT07482787
May 17, 2027Regeneron PharmaceuticalsREGN7508, Acetylsalicylic Acid (ASA)Symptomatic Venous Thromboembolism (VTE)Phase 3NCT07213778
May 17, 2027SanofiPCV21 vaccine, Prevnar 20 vaccine, M-M-R II vaccine and 4 morePneumococcal ImmunizationPhase 3NCT06736041
May 18, 2027E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.10mg QY201 tablet, 20mg QY201 tabletAtopic Dermatitis (AD)Phase 3NCT07180511
May 18, 2027NovoCagrilintideOverweight, ObesityPhase 3NCT07745504
May 18, 2027Takeda Pharmaceutical CompanyZasocitinibPsoriatic ArthritisPhase 3NCT06671496
May 18, 2027Takeda Pharmaceutical CompanyZasocitinib, Active ComparatorPsoriatic ArthritisPhase 3NCT06671483
May 19, 2027Merck & Co.Nemtabrutinib, Fludarabine, Cyclophosphamide and 5 moreChronic Lymphocytic Leukemia, Small Lymphocytic LymphomaPhase 3NCT05624554
May 20, 2027BiogenBIIB017 (peginterferon beta-1a), Interferon beta type 1aMultiple Sclerosis, Relapsing-RemittingPhase 3NCT03958877
May 27, 2027Merck & Co.pembrolizumab, carboplatin, paclitaxel and 2 moreEndometrial NeoplasmsPhase 3NCT05173987
May 27, 2027Otsuka PharmaceuticalCentanafadine XRAttention-deficit/Hyperactivity Disorder, Emotional DysregulationPhase 3NCT07759154
May 27, 2027Taiho Oncology, Inc.TAS6417Advanced or Metastatic NSCLS With Exon 20 Insertion MutationPhase 3NCT05973773
May 28, 2027AstraZenecaDanicopanParoxysmal Nocturnal Hemoglobinuria, PNH and 1 morePhase 3NCT06449001
May 28, 2027AstraZenecalaroprovstat/rosuvastatin 1, laroprovstat/rosuvastatin 2, laroprovstat/rosuvastatin 3 and 5 moreHypercholesterolaemiaPhase 3NCT07619118
May 28, 2027Otsuka PharmaceuticalBPaQM, BPaLM, BPaQ and 1 morePulmonary TuberculosisPhase 3NCT07209761
May 29, 2027Beijing QL Biopharmaceutical Co.,LtdZovaglutide dose 1, Zovaglutide dose 2Overweight , ObesityPhase 3NCT07230119
May 30, 2027Qilu Pharmaceutical Co., Ltd.Meropenem and Pralurbactam, Ceftazidime-avibactam, MetronidazoleIntra-abdominal InfectionsPhase 3NCT06633718
May 30, 2027Shanghai Xinzhi BioMed Co., Ltd.Single dose intravenous injection of BBM-H803Hemophilia APhase 2/3NCT06111638
May 30, 2027Takeda Pharmaceutical CompanyZasocitinibPalmoplantar PsoriasisPhase 3NCT07752108
May 31, 2027Annexon, Inc.TanruprubartGuillain-Barre SyndromePhase 3NCT07020819
May 31, 2027BiogenFelzartamabImmunoglobulin A Nephropathy (IgAN)Phase 3NCT06935357
May 31, 2027Evopoint Biosciences Inc.XNW28012 for injection, XNW28012 Mimetic for InjectionPancreatic CancerPhase 3NCT07823049
May 31, 2027Sarepta Therapeuticsdelandistrogene moxeparvovecDuchenne Muscular DystrophyPhase 3NCT05881408
May 31, 2027Shanghai JMT-Bio Inc.JMT103, zoledronic acidImaging Examination Shows at Least One Site With Bone Metastases From Soild TumorsPhase 3NCT06221072
May 31, 2027Suzhou Immunofoco Biotechnology Co., LtdCAR T cells, ControlGastric AdenocarcinomaPhase 3NCT07103668
May 31, 2027Taisho Pharmaceutical Co., Ltd.'TS-172 20~60 mg/dayHyperphosphatemia Patients on Peritoneal DialysisPhase 3NCT07548853
May 31, 2027Tasly Pharmaceutical Group Co., LtdSusu Xiao'er Zhike Granules, Extremely-low dose Susu Xiao'er Zhike GranulesCoughPhase 3NCT06773117
May 31, 2027Vertex PharmaceuticalsSuzetrigine, PregabalinDiabetic Peripheral Neuropathic PainPhase 3NCT06628908

113 phase 2 readouts too. All 190 phase 2 and 3 readouts in May 2027

June 2027

Phase 3 readouts: 114

Primary completionSponsorDrugConditionPhaseRecord
Jun 20274D Molecular Therapeutics, Inc.4D-150 IVT (3E10 vg/eye), EYLEA® (aflibercept) Injection 2 mg (0.05mL)Macular Neovascularization Secondary to Age-Related Macular DegenerationPhase 3NCT06864988
Jun 2027Alfasigma S.p.A.FilgotinibPolyarticular Course Juvenile Idiopathic ArthritisPhase 3NCT07554495
Jun 2027AlkermesALKS 2680 Dose 1, ALKS 2680 Dose 2Narcolepsy Type 1Phase 3NCT07540897
Jun 2027Ascendis Pharma Bone Diseases A/SPalopegteriparatide Experimental Arm, Palopegteriparatide Control ArmHypoparathyroidism, Endocrine System Diseases and 1 morePhase 3NCT07081997
Jun 2027Asklepion Pharmaceuticals, LLCL-citrullineSickle Cell DiseasePhase 3NCT06989567
Jun 2027Aurion BiotechCombination Product: AURN001 + Y-27632Corneal Edema, Corneal Endothelial Dysfunction and 2 morePhase 3NCT07368959
Jun 2027Jiangsu Hengrui MedicineHRS8179 injection, HRS8179 blank preparation.Severe Cerebral Edema Following Large Hemispheric InfarctionPhase 2/3NCT06732648
Jun 2027Sino Biopharmaceutical LimitedAngiotensin II Injection, 0.9% sodium chloride injectionVasodilatory ShockPhase 3NCT06351150
Jun 2027Day One Biopharmaceuticals, Inc.Tovorafenib, Chemotherapeutic AgentLow-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma and 1 morePhase 3NCT05566795
Jun 2027Denali Therapeutics Inc.tividenofusp alfaMucopolysaccharidosis IIPhase 2/3NCT06075537
Jun 2027Genexine, Inc.Efepoetin Alfa, Darbepoetin AlfaAnemia of Chronic Kidney DiseasePhase 3NCT06466785
Jun 2027Genfleet Therapeutics (Shanghai) Inc.GFH375, ChemotherapyMetastatic Pancreatic CancerPhase 3NCT07262567
Jun 2027Genmab A/sEpcoritamab, Cyclophosphamide, Rituximab and 3 moreDiffuse Large B-Cell LymphomaPhase 3NCT05578976
Jun 2027Gilead SciencesSacituzumab govitecan-hziy (SG), Pembrolizumab, CapecitabineTriple Negative Breast CancerPhase 3NCT05633654
Jun 2027Humacyte, Inc.Acellular Tissue Engineered Vessel (ATEV), AVFEnd Stage Renal Disease (ESRD)Phase 3NCT05908084
Jun 2027ITM Solucin GmbH177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) …, CAPTEM (Capecitabine and Temozolomide), Amino-Acid Solution and 2 moreNeuroendocrine TumorsPhase 3NCT04919226
Jun 2027Immutep S.A.S.eftilagimod alfa, carboplatin plus paclitaxel, cisplatin or carboplatin + pemetrexed and 1 moreAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 3NCT06726265
Jun 2027InnoBM Pharmaceuticals Co., Ltd.Magnesium Microspheres, cTACEHepatocellular Carcinoma Non-ResectablePhase 3NCT06779461
Jun 2027Ionis Pharmaceuticals IncOlezarsenFamilial Chylomicronemia SyndromePhase 3NCT05185843
Jun 2027Jiangsu Hengrui MedicinePyrotinibBreast CancerPhase 3NCT03980054
Jun 2027Lb Pharmaceuticals IncLB-102 (50 mg tablet), LB-102 (100 mg tablet)SchizophreniaPhase 3NCT07363577
Jun 2027Lantheus Holdings, Inc.[18F]PI-2620Alzheimer DiseasePhase 3NCT05641688
Jun 2027Lepu Biopharma Co., Ltd.MRG004A plus best supportive careAdvanced Pancreatic CancerPhase 3NCT07138846
Jun 2027Lupin Ltd.Mexiletine granules for prolonged-release oral suspensionMyotonic DystrophyPhase 3NCT06523400
Jun 2027MindRank AI LtdMDR-001Overweight or ObesityPhase 3NCT07274137
Jun 2027Pharvaris Netherlands B.V.deucrictibantHereditary Angioedema, Hereditary Angioedema Type I and 15 morePhase 2/3NCT05396105
Jun 2027Pharvaris Netherlands B.V.DeucrictibantAcquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)Phase 3NCT07266805
Jun 2027PleoPharma, Inc.PP-01, NabiloneCannabis WithdrawalPhase 3NCT07644052
Jun 2027Qilu Pharmaceutical Co., Ltd.ESG401, Investigator's Choice ChemotherapyTriple-Negative Breast Cancer (TNBC)Phase 3NCT06732323
Jun 2027Qilu Pharmaceutical Co., Ltd.Voclosporin（QL1074）Lupus NephritisPhase 3NCT06406205
Jun 2027Renibus Therapeutics, Inc.VeverimerCKD, Metabolic AcidosisPhase 3NCT07355062
Jun 2027RenovoRx, Inc.Gemcitabine, nab-paclitaxel, RenovoCathLocally Advanced Pancreatic CancerPhase 3NCT03257033
Jun 2027ResilienceGutyCareIBDPhase 3NCT07043036
Jun 2027SDK Therapeutics, Inc.Oral ATO, IV Arsenic Trioxide, all-trans retinoic acid (ATRA)Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia and 7 morePhase 3NCT07296445
Jun 2027Savara IncMolgramostimAutoimmune Pulmonary Alveolar ProteinosisPhase 3NCT06431776
Jun 2027Shanghai HEP Pharmaceutical Co., Ltd.Hepalatide 2.1mgHepatitis D, ChronicPhase 3NCT07309380
Jun 2027Sichuan Baili Pharmaceutical Co., Ltd.BL-B01D1, Liposomal doxorubicin, Paclitaxel or TopotecanEpithelial Ovarian Cancer, Fallopian Tube Cancer and 1 morePhase 3NCT06994195
Jun 2027Sichuan Baili Pharmaceutical Co., Ltd.BL-M07D1, Investigator's choice of chemotherapyGastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaPhase 3NCT07152405
Jun 2027Sichuan Baili Pharmaceutical Co., Ltd.BL-B01D1, Docetaxel or PaclitaxelUrothelial CarcinomaPhase 3NCT06857175
Jun 2027Sinotau Pharmaceutical GroupXTR004Coronary Artery Disease(CAD)Phase 3NCT07439133
Jun 2027Vedanta Biosciences, Inc.VE303Clostridium Difficile, Clostridium Difficile Infections and 8 morePhase 3NCT06237452
Jun 2027Veradermics, IncVDPHL01 QD, VDPHL01 BIDAndrogenetic Alopecia (AGA), Androgenetic Alopecia and 3 morePhase 3NCT07146022
Jun 2027Verrica Pharmaceuticals Inc.VP-102Common Warts, Common Warts (Verruca Vulgaris) and 2 morePhase 3NCT07246590
Jun 1, 2027Brainfarma Industria Química e Farmacêutica S/AExperimental: Pregabalin XR, Comparator: Dorene TabsDiabetic Neuropathy, Neuropathic Pain and 1 morePhase 3NCT07712913
Jun 1, 2027Chongqing Claruvis Pharmaceutical Co., Ltd.Recombinant botulinum toxin type A for injection (YY001)Upper Limb SpasticityPhase 3NCT07478822
Jun 1, 2027EBI Anti Sepsis BVEA-230 90mg/kg/hourCoronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)Phase 3NCT07357675
Jun 1, 2027Shanghai Henlius BiotechHLX22, Pembrolizumab, Trastuzumab and 2 moreGastroesophageal-junction Cancer, Monoclonal Antibody and 2 morePhase 3NCT06532006
Jun 1, 2027Shanghai JMT-Bio Inc.JMT101, Irinotecan, RegorafenibMetastatic Colorectal Cancer (mCRC)Phase 3NCT07134205
Jun 1, 2027Sinotau Pharmaceutical GroupLutetium[177Lu] Oxodotreotide InjectionAdvanced Neuroendocrine NeoplasmPhase 2/3NCT06398444
Jun 2, 2027NovartisPelabresibHematologic Malignancy, Solid Tumor and 1 morePhase 3NCT06401356
Jun 2, 2027SanofiDupilumab, Fexofenadine (loratadine if not available)PruritusPhase 3NCT05263206
Jun 3, 2027NovartisRemibrutinib Dose A, Remibrutinib Dose BHidradenitis SuppurativaPhase 3NCT06840392
Jun 6, 2027Shanghai Henlius BiotechHLX13, US-sourced YERVOY®, EU-sourced YERVOY®Hepatocellular Carcinoma (HCC)Phase 3NCT06841185
Jun 6, 2027Vertex PharmaceuticalsCTX001Sickle Cell Disease, Hydroxyurea Failure and 3 morePhase 3NCT05329649
Jun 7, 2027Cybin IRL LimitedCYB003, Psychological SupportMajor Depressive Disorder (MDD), Depression in Adults and 4 morePhase 3NCT06793397
Jun 7, 2027JemincareJYB1904Chronic Spontaneous UrticariaPhase 3NCT07402213
Jun 7, 2027PfizerPG4 Multivalent Vaccine, 20 Valent Pneumococcal Conjugate Vaccine (20vPnC)Pneumococcal DiseasePhase 3NCT07794748
Jun 7, 2027SanofiPCV21 vaccine, 20vPCV licensed vaccinePneumococcal Immunization, Healthy VolunteersPhase 3NCT07348692
Jun 8, 2027Johnson & JohnsonGuselkumabCrohn's DiseasePhase 3NCT06408935
Jun 8, 2027Takeda Pharmaceutical CompanyVedolizumab, UpadacitinibCrohn's DiseasePhase 3NCT06227910
Jun 9, 2027Beijing VDJBio Co., LTD.Recombinant Humanized Anti-Interleukin-6 Receptor Monoclon…Anti IL-6R, Castleman's Disease, MulticentricPhase 3NCT07872423
Jun 9, 2027NovoCagriSemaDiabetes Mellitus, Type 2Phase 3NCT07817251
Jun 9, 2027Vertex PharmaceuticalsCTX001Beta-Thalassemia, Thalassemia and 5 morePhase 3NCT05477563
Jun 11, 2027Haisco Pharmaceutical Group Co., Ltd.HSK39004 Inhalation SuspensionCOPD (Chronic Obstructive Pulmonary Disease)Phase 3NCT07658339
Jun 15, 2027Applied Biology, Inc.CS-001Canities, Grey HairPhase 3NCT06745336
Jun 15, 2027Boehringer IngelheimBI 1291583BronchiectasisPhase 3NCT06872892
Jun 16, 2027AmgenMaridebart cafraglutide, AutoinjectorObesity, OverweightPhase 3NCT07871409
Jun 18, 2027Regeneron PharmaceuticalsMibavademabMonogenic ObesityPhase 3NCT07220772
Jun 21, 2027Intra-Cellular Therapies, Inc.Lumateperone high dose, Lumateperone low doseIrritability Associated With Autism Spectrum DisorderPhase 3NCT06706674
Jun 21, 2027Intra-Cellular Therapies, Inc.Lumateperone high dose, Lumateperone low doseIrritability Associated With Autism Spectrum DisorderPhase 3NCT06690398
Jun 24, 2027Merck & Co.SuvorexantInsomniaPhase 3NCT06655883
Jun 25, 2027AstraZenecaTezepelumab, Budesonide/formoterol, Albuterol/budesonide (AIRSUPRA®) and 2 moreSevere AsthmaPhase 3NCT06473779
Jun 28, 2027Brainfarma Industria Química e Farmacêutica S/Adipyrone monohydrate 1000 mg + chlorpheniramine maleate 4 …, dipyrone monohydrate 500 mg + chlorpheniramine maleate 2 m…Common Cold/Flu, Nasal Congestion and 1 morePhase 3NCT07626437
Jun 28, 2027Bristol-Myers SquibbXanomeline/Trospium ChlorideMania, Bipolar DisorderPhase 3NCT07140913
Jun 29, 2027Psicofarma, S.A. De C.V.App AURORA (Digital Therapy) + conventional treatment, Pharmacological conventional treatmentGeneral Anxiety DisorderPhase 3NCT07477990
Jun 30, 2027AmgenEtelcalcetideSecondary HyperparathyroidismPhase 3NCT03969329
Jun 30, 2027AmgenSotorasib, PembrolizumabNon-Small Cell Lung Cancer (NSCLC)Phase 3NCT05920356
Jun 30, 2027Ascentage Pharma Group Internationalolverembatinib, BosutinibChronic Myeloid Leukemia, CML and 1 morePhase 3NCT06423911
Jun 30, 2027AstraZenecaDurvalumab, cisplatin + fluorouracil, cisplatin + capecitabine and 1 moreEsophageal Squamous Cell CarcinomaPhase 3NCT04550260
Jun 30, 2027BeOne Medicines Ltd.Tislelizumab, Cisplatin, Gemcitabine Hydrochloride and 1 moreUrothelial CarcinomaPhase 3NCT03967977
Jun 30, 2027Belite Bio, IncTinlarebantGeographic AtrophyPhase 3NCT05949593
Jun 30, 2027Csl LtdCSL511 Fibrinogen concentrate (human), CryoprecipitateAcquired Fibrinogen DeficiencyPhase 3NCT06617897
Jun 30, 2027CSPC Pharmaceutical GroupBempedoic Acid TabletPrimary HyperlipidemiaPhase 3NCT07623915
Jun 30, 2027Cutiss AgdenovoSkin(TM), STSGBurnsPhase 3NCT06745557
Jun 30, 2027Cali Pharmaceuticals LLCCPL-01Postoperative Pain, BunionPhase 3NCT07490496
Jun 30, 2027Changchun GeneScience Pharmaceutical Co., Ltd.Nano-crystalline Megestrol Acetate Oral Suspension, Standard TherapyMetastatic (Stage IV) Non-squamous Non-small Cell Lung Cancer (Nsq-NSCLC) With Driver Gene Negativity, Untreated With Systemic TherapyPhase 3NCT06961188
Jun 30, 2027Changchun GeneScience Pharmaceutical Co., Ltd.Nanocrystalline Megestrol Acetate, Standard Antitumor TherapyCachexia, Hepatocellular CarcinomaPhase 3NCT07356037
Jun 30, 2027Changchun GeneScience Pharmaceutical Co., Ltd.Nano-crystalline Megestrol Acetate Oral Suspension, Standard TherapyNon-small Cell Lung CancerPhase 3NCT07150663
Jun 30, 2027Changchun GeneScience Pharmaceutical Co., Ltd.Nano-crystalline Megestrol Acetate Oral Suspension, standard treatmentHead and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk FactorsPhase 3NCT06772428
Jun 30, 2027Cidara TherapeuticsMK-1406InfluenzaPhase 3NCT07159763
Jun 30, 2027Doron Therapeutics Inc.PTP-01Knee OsteoarthritisPhase 3NCT07219771
Jun 30, 2027Gan & Lee Pharmaceuticals Co., Ltd.GZR18, Semaglutide(Wegovy® )Obesity/Overweight in AdultPhase 3NCT07150975
Jun 30, 2027Gipfel Life Sciences GmbHGalunisertib + Nerandomilast CombinationALS (Amyotrophic Lateral Sclerosis)Phase 2/3NCT07321860
Jun 30, 2027HELP Therapeutics Co., Ltd.HiCM-188 therapy, CABG surgeryHeart FailurePhase 3NCT07496372
Jun 30, 2027Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Roflumilast Foam 0.3%Seborrheic DermatitisPhase 3NCT07683806
Jun 30, 2027Roche HoldingAlectinib, Atezolizumab, Pemetrexed and 9 moreNon-Small Cell Lung CancerPhase 2/3NCT03178552
Jun 30, 2027Roche HoldingPDS With Ranibizumab (100 mg/mL), Ranibizumab (10 mg/mL)Neovascular Age-related Macular Degeneration, nAMDPhase 3NCT05562947
Jun 30, 2027Roche HoldingAstegolimabChronic Obstructive Pulmonary DiseasePhase 3NCT05878769
Jun 30, 2027Roche HoldingAtezolizumab, Bevacizumab, Pemetrexed and 2 moreNeoplasmsPhase 3NCT05112965
Jun 30, 2027IBSA Institut BiochimiqueSodium hyaluronate solution - 3.36%, Sterile buffered solutionOsteo Arthritis of the KneePhase 3NCT07819461
Jun 30, 2027Il-Yang Pharm. Co., Ltd.Radotinib HClChronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase and 2 morePhase 3NCT03459534
Jun 30, 2027Innovent BiologicsIBI343Pancreatic CancerPhase 3NCT07066098
Jun 30, 2027Johnson & JohnsonNipocalimabMyasthenia GravisPhase 2/3NCT05265273
Jun 30, 2027Jiangsu Hengrui MedicineSHR-A1811, Ramucirumab / Paclitaxel/ Docetaxel/ IrinotecanHER2-positive Advanced Gastric Cancer or Gastroesophageal Junction AdenocarcinomaPhase 3NCT06123494
Jun 30, 2027Kexing Biopharm Co., Ltd.Human interferon α1b Inhalation SolutionRespiratory Syncytial Virus InfectionsPhase 3NCT06363370
Jun 30, 2027Lunan Better Pharmaceutical Co., LTD.Isosorbide oral solutionMeniere´s DiseasePhase 2/3NCT06765993
Jun 30, 2027MeiraGTx Ocular UK LtdAAV5-hRKp.RPGRRetinitis PigmentosaPhase 3NCT05926583
Jun 30, 2027MicuRxcontezolid acefosamil (IV)/contezolid (PO), Linezolid (IV and PO)Diabetic Foot InfectionPhase 3NCT05369052
Jun 30, 2027Mirum PharmaceuticalsBrelovitug 300 mg, Bulevirtide 2 mg and Brelovitug - 300 mgChronic Hepatitis D InfectionPhase 3NCT07200908
Jun 30, 2027Norroy Bioscience Co., LTD68-Ga-NYM032Prostate Cancer (Diagnosis)Phase 3NCT07615101
Jun 30, 2027Qilu Pharmaceutical Co., Ltd.ESG401, Eribulin, capecitabine, gemcitabine or vinorelbine (Treatm…Metastatic Breast CancerPhase 3NCT06383767
Jun 30, 2027Shanghai Hutchison Pharmaceuticals LimitedSHPL-49 InjectionAcute Ischemic StrokePhase 3NCT07241520
Jun 30, 2027StemCyte, Inc.REGENECYTELong COVID, Post-COVID-19 Condition and 2 morePhase 3NCT07184385
Jun 30, 2027Thryv Therapeutics, Inc.baseline lead-in, THRV-1268Long QT Syndrome (LQTS) 2Phase 2/3NCT07277582

199 phase 2 readouts too. All 313 phase 2 and 3 readouts in Jun 2027

July 2027

Phase 3 readouts: 69

Primary completionSponsorDrugConditionPhaseRecord
Jul 2027AbbVieElagolix, Combined Oral ContraceptiveEndometriosisPhase 3NCT04333576
Jul 2027AbbVieUpadacitinib (ABT-494)Ulcerative Colitis (UC)Phase 3NCT03006068
Jul 2027AbbVieVenetoclax, AzacitidineMyelodysplastic Syndrome (MDS)Phase 3NCT04401748
Jul 2027Alvotech Swiss AGAVT29 (proposed aflibercept HD biosimilar), Eylea HD (aflibercept HD)Diabetic Macular EdemaPhase 3NCT07489131
Jul 2027Amicus TherapeuticsCipaglucosidase alfa, MiglustatGlycogen Storage Disease Type II Infantile OnsetPhase 3NCT04808505
Jul 2027Apellis Pharmaceuticals, Inc.PegcetacoplanC3G, IC-MPGN and 10 morePhase 3NCT05809531
Jul 2027Biocells (Beijing) Biotech Co.,LtdBXOS110AISPhase 3NCT07520565
Jul 2027Biotheus Inc.PM8002, Nab-PaclitaxelTriple Negative Breast Cancer(TNBC)Phase 3NCT06419621
Jul 2027Caliway Biopharmaceuticals Co., Ltd.CBL-514 Injection, 0.9% Sodium ChlorideSubcutaneous FatPhase 3NCT07140939
Jul 2027Eli Lilly and CompanyRetatrutideObesity, OverweightPhase 3NCT07232719
Jul 2027GL Pharm Tech CorporationW2505, W2505-P1, W2505-R and 1 moreErectile DysfunctionsPhase 3NCT07859202
Jul 2027Infectopharm Arzneimittel GmbH5% Permethrin Creme, 10% Permethrin CremeScabiesPhase 3NCT06380452
Jul 2027Intellia Therapeuticsnexiguran ziclumeranNeuromuscular Disease, Neuromuscular Diseases (NMD) and 18 morePhase 3NCT06672237
Jul 2027MesoblastRexlemestrocel-L + HA mixtureDegenerative Disc DiseasePhase 3NCT06325566
Jul 2027Nervgen Pharma Corp.NVG-291Chronic Spinal Cord InjuryPhase 3NCT07799532
Jul 2027Neurocrine BiosciencesNBI-1065845Major Depressive DisorderPhase 3NCT06963021
Jul 2027Neurocrine BiosciencesNBI-1065845Major Depressive DisorderPhase 3NCT06911112
Jul 2027Neurocrine BiosciencesNBI-1065845Major Depressive DisorderPhase 3NCT06786624
Jul 2027PT. Prodia Stem Cell Indonesia1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CMRetinitis PigmentosaPhase 2/3NCT05909488
Jul 2027Paradigm Biopharmaceuticals Limited..Pentosan Polysulfate Sodium twice weeklyOsteoarthritis, KneePhase 3NCT06917404
Jul 2027SANGMYUNG innovationReference Drug, SMO1Retinal Vein Occlusion With Macular EdemaPhase 3NCT07708142
Jul 2027Shanghai Henlius BiotechHLX15-IV, DarzalexNewly Diagnosed Multiple MyelomaPhase 3NCT06895512
Jul 2027Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SKB264, Nab-paclitaxel, Paclitaxel and 1 moreMetastatic Breast CancerPhase 3NCT07071337
Jul 2027Sinocelltech Ltd.SCTB14, PembrolizumabNon-Small Cell Lung Carcinoma (NSCLC)Phase 3NCT07362459
Jul 2027Sinovac BiotechSinovac PCV13, Prevenar 13™Pneumococcal Infectious DiseasesPhase 3NCT07593924
Jul 2027Sunshine Lake Pharma Co., Ltd.Mitizodone Phosphate tabletsDepressive Disorder, MajorPhase 2/3NCT04984512
Jul 2027Telix Pharmaceuticals LimitedTLX-101-Tx + Lomustine, TLX101-TxNeoplastic Disease, Glioblastoma and 4 morePhase 3NCT07100730
Jul 2027Trust Bio-sonics, Inc.NH002 (Perflutren Lipid Microspheres) Injectable SuspensionCardiac DiseasesPhase 3NCT07740421
Jul 2027ViatrisSelatogrelAcute Myocardial InfarctionPhase 3NCT04957719
Jul 2027Argenx SEEfgartigimod PH20 SCPrimary Sjogrens DiseasePhase 3NCT06684847
Jul 1, 2027Rapa Therapeutics LLCRAPA-501 Autologous T stem cellsAmyotrophic Lateral SclerosisPhase 2/3NCT04220190
Jul 1, 2027Shanghai Yizhong Pharmaceutical Co., Ltd.paclitaxel polymeric micelles for injection, Gemcitabine Hydrochloride for Injection, Paclitaxel for Injection (albumin bound )Pancreatic Cancer MetastaticPhase 3NCT06752811
Jul 1, 2027Shijiazhuang Yiling Pharmaceutical Co. LtdXY0206, Salvage ChemotherapyAcute Myeloid Leukemia With FLT3/ITD MutationPhase 3NCT05876832
Jul 1, 2027Viking TherapeuticsVK2735Weight LossPhase 3NCT07104383
Jul 1, 2027Viking TherapeuticsVK2735Weight LossPhase 3NCT07104500
Jul 5, 2027AmgenTarlatamab, DurvalumabExtensive-Stage Small-Cell Lung Cancer, Small-Cell Lung CancerPhase 3NCT06211036
Jul 6, 2027LundbeckEptinezumabEpisodic MigrainePhase 3NCT05897320
Jul 9, 2027Chendu DIAO Pharmaceutical Group CO., LTD.DA-302168SOverweight and ObesityPhase 3NCT07629544
Jul 9, 2027GSKmRNA Seasonal Flu vaccine, Comparator 1, Comparator 2Influenza, HumanPhase 3NCT07851246
Jul 9, 2027Sanofiriliprubart, IVIgChronic Inflammatory Demyelinating PolyneuropathyPhase 3NCT06290141
Jul 10, 2027Akeso–Atopic DermatitisPhase 3NCT06767540
Jul 11, 2027Merck & Co.Sacituzumab tirumotecan, Pembrolizumab, Paclitaxel and 3 moreBreast NeoplasmsPhase 3NCT06312176
Jul 12, 2027InventisBio Co., LtdD-2570 Tablet, BMS-986165 TabletPlaque PsoriasisPhase 3NCT07326813
Jul 14, 2027Merck & Co.Bomedemstat, Anagrelide, Busulfan and 2 moreEssential ThrombocythemiaPhase 3NCT06079879
Jul 15, 2027AstraZenecaAcalabrutinib, Venetoclax, ObinutuzumabChronic Lymphocytic Leukemia or Small Lymphocytic LymphomaPhase 3NCT05057494
Jul 15, 2027Jiangsu Simcere Pharmaceutical Co., Ltd.Trilaciclib, Etoposide Injection, Carboplatin or Cisplatin Injection and 1 moreMyelosuppressionPhase 3NCT07881705
Jul 15, 2027SanofiFrexalimab, MRI contrast-enhancing preparationsMultiple SclerosisPhase 3NCT07325292
Jul 18, 2027AmgenAvacopanVasculitisPhase 3NCT06321601
Jul 20, 2027Roche HoldingPDS Implant Pre-Filled with 100 mg/mL Ranibizumab, Intravitreal Ranibizumab 0.5 mg Injection, Ranibizumab refill exchangeDiabetic Macular EdemaPhase 3NCT04108156
Jul 22, 2027Danyang Huichuang Medical Equipment Co., Ltd.NirsCure 6000, Sham DeviceAlzheimer s DiseasePhase 3NCT07262645
Jul 22, 2027Merck & Co.MK-8527, FTC/TDFHuman Immunodeficiency Virus (HIV), HIV Pre-Exposure ProphylaxisPhase 3NCT07044297
Jul 22, 2027PfizerPF-07248144, Fulvestrant, Everolimus and 1 moreBreast CancerPhase 3NCT07062965
Jul 23, 2027SanofiRilzabrutinibSickle Cell DiseasePhase 3NCT06975865
Jul 27, 2027AstraZenecaBaxdrostatPrimary HyperaldosteronismPhase 3NCT07007793
Jul 28, 2027AstraZenecaDato-DXd, Durvalumab, Paclitaxel and 4 moreBreast CancerPhase 3NCT06103864
Jul 28, 2027InventisBio Co., LtdD-2570Plaque PsoriasisPhase 3NCT07130604
Jul 30, 2027AstraZenecaLaroprovstat, Rosuvastatin 1, Rosuvastatin 2 and 2 moreHypercholesterolaemiaPhase 3NCT07619131
Jul 30, 2027BayerDarolutamide (BAY1841788, Nubeqa), ADTBiochemically Recurrent Prostate CancerPhase 3NCT05794906
Jul 30, 2027Genmab A/sAcasunlimab, Pembrolizumab, DocetaxelPD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLCPhase 3NCT06635824
Jul 30, 2027Haisco Pharmaceutical Group Co., Ltd.HSK16149 20mg-40mg BIDCentral Neuropathic PainPhase 3NCT06422117
Jul 30, 2027Johnson & JohnsonTalquetamab, Daratumumab, Pomalidomide and 1 moreMultiple MyelomaPhase 3NCT05455320
Jul 30, 2027Jiangxi Qingfeng Pharmaceutical Co. Ltd.GP681 40mg, GP681 SimulantInfluenzaPhase 3NCT06574503
Jul 30, 2027PfizerRitlecitinibStable Nonsegmental Vitiligo, Active Nonsegmental VitiligoPhase 3NCT06072183
Jul 30, 2027Shanghai Bovax Biotechnology Co., Ltd.9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33…Genital Wart, Penile Cancer and 8 morePhase 3NCT06465914
Jul 31, 2027AmgenABP 938 8 mg, Aflibercept (US) 8 mgNeovascular Age-related Macular Degeneration, nAMDPhase 3NCT07614776
Jul 31, 2027Annexon, Inc.Vonaprument, Sham AdministrationGeographic AtrophyPhase 3NCT06510816
Jul 31, 2027MAIA Biotechnology, Inc.6-Thio-2'-Deoxyguanosine, Cemiplimab, Docetaxel and 2 moreCarcinoma, Non-Small -Cell LungPhase 3NCT06908304
Jul 31, 2027ShionogiSecutrelvirCOVID-19Phase 3NCT07746544
Jul 31, 2027Taisho Pharmaceutical Co., Ltd.TS-172Hyperphosphatemia Patients on HemodialysisPhase 3NCT07285304

117 phase 2 readouts too. All 186 phase 2 and 3 readouts in Jul 2027

August 2027

Phase 3 readouts: 65

Primary completionSponsorDrugConditionPhaseRecord
Aug 2027Aveo Pharmaceuticals, INC.Ficlatuzumab, CetuximabMetastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell CarcinomaPhase 3NCT06064877
Aug 2027AbbVieVenetoclaxChronic Lymphocytic Leukemia, Acute Myeloid Leukemia and 4 morePhase 3NCT03844048
Aug 2027AbbVieRisankizumab, VedolizumabUlcerative ColitisPhase 3NCT06880744
Aug 2027Ascendis Pharma A/SPalopegteriparatideHypoparathyroidismPhase 3NCT07706764
Aug 2027Ascentage Pharma Group InternationalLisaftoclax (APG-2575), Acalabrutinib, Fludarabine and 3 moreCLL/SLLPhase 3NCT06319456
Aug 2027Biohaven PharmaceuticalsBHV-8000 10mg, BHV-8000 20 mgParkinson DiseasePhase 2/3NCT06976268
Aug 2027Bostal Drug Delivery Co., LtdBrexpiprazole for ER injection, 45 mg, Brexpiprazole for ER injection, 100 mgSchizophreniaPhase 2/3NCT07742280
Aug 2027Bostal Drug Delivery Co., Ltd30 mg B2227, 70 mg B2227, 150 mg B2227 and 4 moreSchizophreniaPhase 2/3NCT07722728
Aug 2027Caliway Biopharmaceuticals Co., Ltd.CBL-514 Injection, 0.9% Sodium ChlorideSubcutaneous FatPhase 3NCT07526974
Aug 2027Sino Biopharmaceutical LimitedTQB2102 Injection, Trifluridine /Tipiracil (TAS-102) tablets / Fruquintinib /…HER2 IHC3+ Advanced Colorectal CancerPhase 3NCT07483684
Aug 2027Crinetics PharmaceuticalsPaltusotineCarcinoid Syndrome, Carcinoid and 7 morePhase 3NCT07087054
Aug 2027DalCor PharmaceuticalsDalcetrapibAcute Coronary SyndromePhase 3NCT05918861
Aug 2027Eli Lilly and CompanyOrforglipronObesity, OverweightPhase 3NCT06972459
Aug 2027Eli Lilly and CompanyOrforglipronObesity, Overweight and 1 morePhase 3NCT06993792
Aug 2027Eli Lilly and CompanyOrforglipronObesity, Overweight and 1 morePhase 3NCT06972472
Aug 2027GC Biopharma CorpMG1111 (Barycela inj.), VARIVAX™Varicella (Chickenpox), Chickenpox VaccinePhase 3NCT07054099
Aug 2027HK inno.N CorporationIN-B00009Diabetes (DM), Diabetes Mellitus Type 2Phase 3NCT07308184
Aug 2027Integrant Pty LtdIntra-Articular Injection of Growth Hormone and Platelet-R…Arthritis Ankle, Arthritis KneePhase 2/3NCT06907121
Aug 2027Ionis Pharmaceuticals IncobudanersenAngelman SyndromePhase 3NCT06914609
Aug 2027Lipocine Inc.LPCN 1154ADepression, Postpartum, Postpartum Depression (PPD) and 4 morePhase 3NCT07822321
Aug 2027Nanjing IASO Biotechnology Co., Ltd.Equecabtagene Autoleucel Injection, Daratumumab, Pomalidomide and 2 moreMultiple MyelomaPhase 3NCT06464991
Aug 2027Onconic Therapeutics Inc.JP-1366 10 mg, Lanston Capsule 15 mgPeptic UlcerPhase 3NCT06439563
Aug 2027Opus Genetics, Inc.0.75% Phentolamine Ophthalmic SolutionVision Loss Night, Vision DisordersPhase 3NCT07140783
Aug 2027Otsuka PharmaceuticalEB-1020 (Centanafadine) low dose, EB-1020 (Centanafadine) high doseAttention-Deficit Hyperactivity Disorder(ADHD)Phase 2/3NCT07086313
Aug 2027Otsuka PharmaceuticalEB-1020 (Centanafadine) low dose, EB-1020 (Centanafadine) high doseAttention-Deficit Hyperactivity Disorder(ADHD)Phase 3NCT07087327
Aug 2027Sagimet Biosciences Inc.DenifanstatAcne VulgarisPhase 3NCT07863193
Aug 2027Jiangsu Hengrui MedicineHRS-8080 Tablet, Fulvestrant injection, Exemestane tablets and 3 moreLocally Advanced Breast Cancer, Metastatic Breast CancerPhase 3NCT07024173
Aug 2027Stealth BioTherapeutics CorpElamipretideAge Related Macular Degeneration (ARMD)Phase 3NCT06373731
Aug 2027Sunshine Lake Pharma Co., Ltd.Lerotinib, Irinotecan/TegafurEsophageal CancerPhase 3NCT04415853
Aug 2027Travere Therapeutics, Inc.PegtibatinaseHomocystinuriaPhase 3NCT06247085
Aug 2027Trevi Therapeutics, Inc.NAL ERIdiopathic Pulmonary FibrosisPhase 3NCT07868419
Aug 2027Ultragenyx Pharmaceutical Inc.No Investigational Product, Adjuvant Immunomodulatory (IM) TherapyMucopolysaccharidosis IIIA, MPS IIIA and 2 morePhase 3NCT04360265
Aug 2027Ultragenyx Pharmaceutical Inc.Triheptanoin, MCT OilLong-chain Fatty Acid Oxidation Disorders (LC-FAOD)Phase 3NCT05933200
Aug 2027medac GmbHMC0518, BATSteroid-refractory Acute Graft-versus-host DiseasePhase 3NCT04629833
Aug 1, 2027Bluefin Biomedicine, Inc.BFB759Hidradenitis Suppurativa (HS)Phase 2/3NCT07287644
Aug 2, 2027AstraZenecaOsimertinibNon-Small Cell Lung CancerPhase 3NCT05120349
Aug 4, 2027PfizerElranatamab, LenalidomideMultiple MyelomaPhase 3NCT05317416
Aug 5, 2027Johnson & JohnsonNipocalimabHemolytic Disease of the Fetus and NewbornPhase 3NCT05912517
Aug 6, 2027Nature Cell Co. Ltd.JointStemOsteoarthritis, KneePhase 2/3NCT04368806
Aug 7, 2027BiogenTofersenAmyotrophic Lateral Sclerosis Associated With a SOD1 Gene MutationPhase 3NCT04856982
Aug 9, 2027Bristol-Myers SquibbGolcadomide, Rituximab, Cyclophosphamide and 3 moreLarge B-cell LymphomaPhase 3NCT06356129
Aug 10, 2027NovartisBION-1301IgA Nephropathy, Immunoglobulin A NephropathyPhase 3NCT05852938
Aug 17, 2027Bristol-Myers SquibbBMS-986489 (Atigotatug+Nivolumab), Atezolizumab, Carboplatin and 1 moreExtensive-Stage Small Cell Lung CancerPhase 3NCT06646276
Aug 20, 2027AmgenMaridebart cafraglutideObesity, Obstructive Sleep ApneaPhase 3NCT07225686
Aug 20, 2027Arrowhead Pharmaceuticalszodasiran InjectionHomozygous Familial HypercholesterolemiaPhase 3NCT07037771
Aug 23, 2027GSKHZ/su vaccineHerpes ZosterPhase 3NCT05371080
Aug 24, 2027AstraZenecaRavulizumabGeneralized Myasthenia Gravis, gMGPhase 3NCT07596784
Aug 25, 2027SanofiPCV21 vaccine, Vaxneuvance vaccine, Hexyon vaccine and 2 morePneumococcal Immunization, Healthy VolunteersPhase 3NCT06975878
Aug 27, 2027GSKBLU-5937Refractory Chronic CoughPhase 3NCT07650084
Aug 27, 2027NovoEtavopivatSickle Cell DiseasePhase 3NCT06612268
Aug 28, 2027Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.HDM1005 1, HDM1005 2Type 2 DiabetesPhase 3NCT07394114
Aug 30, 2027AmgenMaridebart cafraglutideObstructive Sleep ApneaPhase 3NCT07226765
Aug 30, 2027Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.HDM1005 1, HDM1005 2, MazdutideType 2 DiabetesPhase 3NCT07417306
Aug 30, 2027Insud PharmaBenznidazoleChagas DiseasePhase 3NCT04024163
Aug 30, 2027Jiangsu vcare pharmaceutical technology co., LTDVC005 low dose group, VC005 high dose groupModerate to Severe Atopic DermatitisPhase 3NCT06723080
Aug 30, 2027Jiangsu vcare pharmaceutical technology co., LTDVC005 tabletsActive Ankylosing SpondylitisPhase 3NCT07172360
Aug 30, 2027Sofie[18F]FAPI-74 PET/CTEsophageal Cancer, Gastric Cancer (GC) and 1 morePhase 3NCT07217704
Aug 31, 2027Compass Therapeutics, Inc.CTX-009, PaclitaxelBiliary Tract Cancer, Cholangiocarcinoma and 2 morePhase 2/3NCT05506943
Aug 31, 2027Roche HoldingObinutuzumab, Glofitamab, Rituximab and 3 moreLymphomaPhase 3NCT06084936
Aug 31, 2027Il-Yang Pharm. Co., Ltd.Finasteride 5 mg Tablet, single dose, Tamsulosin 0.4Mg CapsuleBenign Prostatic HyperplasiaPhase 3NCT07870759
Aug 31, 2027Minghui Pharmaceutical (Hangzhou) LtdMHB018A injectionThyroid Eye Disease (TED)Phase 3NCT07257185
Aug 31, 2027Mirum PharmaceuticalsBrelovitug (BJT-778), BulevirtideChronic Hepatitis DPhase 2/3NCT07454837
Aug 31, 2027OncoC4, Inc.Gotistobart, DocetaxelNon Small Cell Lung CancerPhase 3NCT05671510
Aug 31, 2027Qilu Pharmaceutical Co., Ltd.QL1706 injection, Vinorelbine Tartrate, Paclitaxel and 3 moreCarcinoma, Non-Small-Cell LungPhase 3NCT05487391
Aug 31, 2027Telix Pharmaceuticals Limited177Lu-TLX250ccRCC, Renal Cell Carcinoma (Kidney Cancer) and 4 morePhase 3NCT07197580

125 phase 2 readouts too. All 190 phase 2 and 3 readouts in Aug 2027

September 2027

Phase 3 readouts: 82

Primary completionSponsorDrugConditionPhaseRecord
Sep 2027AbbVieArmour Thyroid, LevothyroxineHypothyroidismPhase 2/3NCT06345339
Sep 2027AbbVieUpadacitinibCrohn's DiseasePhase 3NCT03345823
Sep 2027AlkermesOLZ/SAMBipolar I Disorder, SchizophreniaPhase 3NCT04987229
Sep 2027Alvogen KoreaAK-D101Attention Deficit Hyperactivity Disorder, Attention-Deficit / Hyperactivity Disorder and 1 morePhase 3NCT07678827
Sep 2027Applied Biologics, LLCBIOxHEAL (human amniotic membrane allograft)Diabetic Foot Ulcer, Amniotic Membrane Placental Allograft and 1 morePhase 3NCT07852338
Sep 2027Birch BioMed IncIP1 control cream (Vehicle base), IP2 - 0.5% w/w FS2Burn Scar, Burn WoundPhase 2/3NCT06807021
Sep 2027Castle Creek Biosciences, LLC.D-FiDystrophic Epidermolysis BullosaPhase 3NCT06892639
Sep 2027Sino Biopharmaceutical LimitedTQB2102 for injection, Trastuzumab injection and Pertuzumab Injection and Docetax…HER2-positive Breast CancerPhase 3NCT07043725
Sep 2027Sino Biopharmaceutical LimitedTQH3906 capsules, Deucravacitinib tablets 6 mgPsoriasisPhase 3NCT07724366
Sep 2027CytokineticsOmecamtiv Mecarbil (OM)Heart Failure, Heart Failure With Reduced Ejection FractionPhase 3NCT06736574
Sep 2027Definium TherapeuticsDT120Major Depressive DisorderPhase 3NCT07592689
Sep 2027Dompé Farmaceutici S.p.ACenegerminNon-Arteritic Anterior Ischemic Optic NeuropathyPhase 3NCT07453888
Sep 2027Dr. Falk Pharma GmbHnorucholic acidPrimary Sclerosing CholangitisPhase 3NCT06886360
Sep 2027Eli Lilly and CompanyOrforglipronHypertensionPhase 3NCT06952530
Sep 2027Eli Lilly and CompanyRetatrutideObesity, Overweight and 1 morePhase 3NCT07035093
Sep 2027Eli Lilly and CompanyOrforglipronHypertension, Overweight or ObesityPhase 3NCT06948435
Sep 2027Eli Lilly and CompanyOrforglipronHypertensionPhase 3NCT06948422
Sep 2027Gan & Lee Pharmaceuticals Co., Ltd.GZR18 injectionOverweight or ObesityPhase 3NCT07292441
Sep 2027Genmab A/sRina-S, Paclitaxel, Topotecan and 2 morePlatinum-resistant Ovarian CancerPhase 3NCT07604766
Sep 2027Jiangsu Hengrui MedicineHR-1703Asthma With Eosinophilic PhenotypePhase 3NCT06653322
Sep 2027IDB VisionCare SDN BHDLow dose atropine sulfate eye dropsMyopia ProgressionPhase 3NCT07329777
Sep 2027Joincare Pharmaceutical Group Industry Co., LtdJKN2401 InjectionChronic Obstructive Pulmonary Disease (COPD)Phase 3NCT07330310
Sep 2027Kardigan, Inc.danicamtivSymptomatic Genetic Dilated CardiomyopathyPhase 2/3NCT07210723
Sep 2027Keymed Biosciences Co.LtdCM336 InjectionMultiple Myeloma (MM)Phase 3NCT07181239
Sep 2027Kyverna Therapeutics, Inc.Standard lymphodepletion regimen, KYV-101Myasthenia Gravis, Generalized Myasthenia GravisPhase 2/3NCT06193889
Sep 2027ML Bio Solutions, Inc.BBP-418 (ribitol)Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)Phase 3NCT05775848
Sep 2027Mabwell (Shanghai) Bioscience Co., Ltd.9MW2821, Toripalimab, Gemcitabine and 1 moreUrothelial CarcinomaPhase 3NCT06592326
Sep 2027Otsuka PharmaceuticalOPC-34712FUM/ Brexpiprazole fumarateAcute SchizophreniaPhase 3NCT05325645
Sep 2027Pharmazz, Inc.Normal Saline, SovateltideAcute Ischemic Stroke, Cerebral StrokePhase 3NCT05691244
Sep 2027Shanghai Minwei Biotechnology Co., LtdMWN109 1, MWN109 2, MWN109 3Overweight , ObesityPhase 3NCT07778693
Sep 2027Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.611Dermatitis, AtopicPhase 3NCT07767253
Sep 2027Ultragenyx Pharmaceutical Inc.DTX301, Oral Corticosteroids, Sodium AcetateOTC DeficiencyPhase 3NCT05345171
Sep 2027X4 Pharmaceuticals, IncMavorixaforNeutropeniaPhase 3NCT06056297
Sep 2027Argenx SEEfgartigimod PH20 SCGeneralized Myasthenia GravisPhase 2/3NCT06392386
Sep 2027Argenx SEempasiprubart, IVIgChronic Inflammatory Demyelinating Polyneuropathy, CIDP and 1 morePhase 3NCT06920004
Sep 1, 2027AstraZenecaDato-DXd, Durvalumab, Capecitabine and 1 moreBreast CancerPhase 3NCT05629585
Sep 1, 2027Lee's Pharmaceutical LimitedSocazolimab+cisplatin/carboplatin+paclitaxel+BevacizumabCervical CancerPhase 3NCT06459687
Sep 1, 2027NovoCagrilintide, SemaglutideCardiovascular DiseasePhase 3NCT05669755
Sep 1, 2027Qilu Pharmaceutical Co., Ltd.QL1706, Bevacizumab, Oxaliplatin injection and 2 moreHepatocellular CarcinomaPhase 2/3NCT05976568
Sep 7, 2027Bristol-Myers SquibbKarXTPsychosis Associated With Alzheimer's DiseasePhase 3NCT05980949
Sep 10, 2027SanofiPCV21 vaccine, Prevnar 20 vaccine, M-M-R II vaccine and 7 morePneumococcal ImmunizationPhase 3NCT06824181
Sep 12, 2027Bristol-Myers SquibbBMS-986365, Enzalutamide, Abiraterone and 2 moreMetastatic Castration-resistant Prostate CancerPhase 3NCT06764485
Sep 13, 2027Takeda Pharmaceutical CompanyVedolizumab IVCrohn's Disease (CD)Phase 3NCT04779320
Sep 15, 2027Shanghai Bovax Biotechnology Co., Ltd.9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,4…, GARDASIL®Cervical Cancer, Vulvar Cancer and 12 morePhase 3NCT04422366
Sep 15, 2027Sinovac BiotechInactivated Hepatitis A Vaccine (Human Diploid Cell) (1 mL), Inactivated Hepatitis A Vaccine (Human Diploid Cell) (0.5 …, Hepatitis A vaccine (inactivated, adsorbed)Hepatitis A VaccinePhase 3NCT07793227
Sep 19, 2027Paradigm TherapeuticsSD-101 Dermal Cream (6%)Epidermolysis Bullosa (EB)Phase 3NCT07482813
Sep 20, 2027Jiangsu Hengrui MedicineSHR-A1904, Paclitaxel, Docetaxel, IrinotecanSecond-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPhase 3NCT06649292
Sep 21, 2027Novartisianalumab s.c. q4w, ianalumab s.c. q12wLupus NephritisPhase 3NCT05126277
Sep 21, 2027PfizerMET097Obesity and OverweightPhase 3NCT07311850
Sep 22, 2027Shanghai Kechow Pharma, Inc.tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or da…MelanomaPhase 3NCT06008106
Sep 23, 2027Roche HoldingNXT007, Human Coagulation Factor VIIIHemophilia APhase 3NCT07416526
Sep 24, 2027AmgenTarlatamabSmall Cell Lung CancerPhase 3NCT07778316
Sep 24, 2027BiogenNusinersenSpinal Muscular AtrophyPhase 3NCT05067790
Sep 24, 2027Merck & Co.Zilovertamab vedotin, Rituximab, Gemcitabine and 3 moreDLBCL, Diffuse Large B-Cell LymphomaPhase 2/3NCT05139017
Sep 24, 2027Takeda Pharmaceutical CompanyVedolizumab IVModerately to Severely Active Ulcerative ColitisPhase 3NCT03221036
Sep 24, 2027The United Bio-Technology (Hengqin) Co., Ltd.UBT251 Injection 2.0 mg, UBT251 Injection 4.0 mg, UBT251 Injection 6.0 mgType 2 DiabetesPhase 3NCT07659574
Sep 27, 2027Cellcolabs Clinical SPV LimitedMesenchymal Stem Cells (MSC), Hyaluronic Acid (HA)Knee Arthritis OsteoarthritisPhase 2/3NCT07542808
Sep 28, 2027IncyteINCA034176, CorticosteroidsChronic Graft-versus-host-diseasePhase 3NCT06585774
Sep 28, 2027Johnson & JohnsonNipocalimab, EfgartigimodMyasthenia GravisPhase 3NCT07217587
Sep 28, 2027Merck & Co.Bomedemstat, HydroxyureaEssential ThrombocythemiaPhase 3NCT06456346
Sep 28, 2027Pfizeribuzatrelvir, remdesivirCOVID-19 InfectionPhase 3NCT07013474
Sep 28, 2027Regeneron Pharmaceuticalsfianlimab, cemiplimabAdvanced Non-Small Cell Lung CancerPhase 2/3NCT05785767
Sep 29, 2027Johnson & JohnsonUstekinumabCrohn Disease, Colitis, Ulcerative and 1 morePhase 3NCT05092269
Sep 29, 2027The United Bio-Technology (Hengqin) Co., Ltd.UBT251 Injection 4.0 mg, UBT251 Injection 6.0 mgObesity & OverweightPhase 3NCT07648225
Sep 30, 2027AstraZenecaSaruparib, Abiraterone Acetate, Darolutamide and 1 moreMetastatic Castration-Sensitive Prostate CancerPhase 3NCT06120491
Sep 30, 2027Avecho BiotechnologyCannabidiol (CBD) Capsule 75mgInsomniaPhase 3NCT05840822
Sep 30, 2027Biomed Industries, Inc.BionetideRett SyndromePhase 3NCT06840496
Sep 30, 2027Bisirna Therapeutics (Suzhou) Co., Ltd.VSA012, Eculizumab (Soliris®)Paroxysmal Nocturnal Hemoglobinuria, PNHPhase 3NCT07816237
Sep 30, 2027CSPC Pharmaceutical GroupSYS6010 injection, Enlonstobart injection, Tislelizumab injection and 1 moreNon-Small Cell Lung CancerPhase 3NCT07633873
Sep 30, 2027CSPC Pharmaceutical GrouprhTNK-tPAAcute Ischemic StrokePhase 3NCT07201688
Sep 30, 2027Centessa Pharmaceuticals plccleminorextonNarcolepsy Type 1, Narcolepsy Type 2Phase 2/3NCT07598708
Sep 30, 2027Chong Kun DangCKD-843 dose#1, CKD-843 dose#2, Dutasteride CapsulesAndrogenetic AlopeciaPhase 3NCT06916793
Sep 30, 2027GrifolsAlpha-1 15%, Liquid Alpha1-PIAlpha 1 Antitrypsin DeficiencyPhase 3NCT07555483
Sep 30, 2027Haisco Pharmaceutical Group Co., Ltd.HSK39004 Dry Powder Inhaler Simulant, HSK39004 Dry Powder Inhaler-0.75mgCOPD (Chronic Obstructive Pulmonary Disease)Phase 3NCT07583849
Sep 30, 2027Inventiva S.A.IVA337NASH - Nonalcoholic SteatohepatitisPhase 3NCT04849728
Sep 30, 2027Ono PharmaceuticalONO-4059Pemphigus, Steroid-resistant PemphigusPhase 3NCT06696716
Sep 30, 2027SanofiAmlitelimab, Topical corticosteroids, Topical tacrolimus or pimecrolimusDermatitis AtopicPhase 3NCT06241118
Sep 30, 2027Shanghai RAAS Blood Products Co., Ltd.SR604Hemophilia A, Hemophilia A and B and 1 morePhase 3NCT07876674
Sep 30, 2027Shanghai Zhimeng Biopharma, Inc.Test drug CB03-154 5mg group, Test drug CB03-154 10mg group, Test drug CB03-154 15mg groupALS (Amyotrophic Lateral Sclerosis)Phase 2/3NCT07082192
Sep 30, 2027Tetra Discovery PartnersZatolmilast/ BPN14770Fragile X SyndromePhase 3NCT05367960
Sep 30, 2027Vanda Pharmaceuticals Inc.TradipitantMotion SicknessPhase 3NCT06138613
Sep 30, 2027Vertex PharmaceuticalsELX/TEZ/IVA, IVACystic FibrosisPhase 3NCT06460506

111 phase 2 readouts too. All 193 phase 2 and 3 readouts in Sep 2027

October 2027

Phase 3 readouts: 44

Primary completionSponsorDrugConditionPhaseRecord
Oct 2027AFT Pharmaceuticals, Ltd.Combogesic® tablets, Acetaminophen 500mgPost Operative Pain, AcutePhase 3NCT07225140
Oct 2027Acacia Pharma LtdRemimazolamPediatric ALLPhase 2/3NCT04851717
Oct 2027BeOne Medicines Ltd.Zanubrutinib, TacrolimusPrimary Membranous NephropathyPhase 2/3NCT05707377
Oct 2027Jiangsu Hengrui MedicineSHR-1918HyperlipidemiaPhase 3NCT07230730
Oct 2027Bukwang PharmaceuticalLurasidone, Background Antidepressant TherapyMajor Depressive Disorder (MDD), Major Depressive Disorder With Psychotic FeaturesPhase 3NCT07781293
Oct 2027Carnot LaboratoriesBofanglutide, SemaglutideType 2 Diabetes Mellitus (T2DM)Phase 3NCT07628985
Oct 2027Chengdu New Radiomedicine Technology Co. LTD.NRT6003 Injection, cTACEUnresectable Hepatocellular CarcinomaPhase 3NCT06900543
Oct 2027Jiangsu Hengrui MedicineHRS-5965Primary IgA NephropathyPhase 3NCT07014826
Oct 2027Chiesi Farmaceutici S.p.A.PRX-102 1 mg/kg every 2 weeks, PRX-102 2 mg/kg every 4 weeksFabry DiseasePhase 2/3NCT05710692
Oct 2027Eli Lilly and CompanyTirzepatideObesity, Weight GainPhase 3NCT06439277
Oct 2027Eli Lilly and CompanyImlunestrant, Tamoxifen, Anastrozole and 2 moreBreast NeoplasmsPhase 3NCT05514054
Oct 2027Eli Lilly and CompanyTirzepatideObesity, OverweightPhase 3NCT05556512
Oct 2027EyePoint PharmaceuticalsEYP-1901, Aflibercept (2.0 mg)Diabetic Macular Edema, DME and 1 morePhase 3NCT07449936
Oct 2027EyePoint PharmaceuticalsEYP-1901, Aflibercept (2.0 mg)Diabetic Macular Edema, DME and 1 morePhase 3NCT07449923
Oct 2027Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.Rupatifen Fumarate Capsules, Rupatadine Fumarate TabletsSeasonal Allergic RhinitisPhase 3NCT07711262
Oct 2027Harmony Biosciences Management, Inc.HBS-301 tabletIdiopathic HypersomniaPhase 3NCT07500090
Oct 2027Harmony Biosciences Management, Inc.HBS-301EDS, Cataplexy and 2 morePhase 3NCT07675135
Oct 2027J-Pharma Co., Ltd.Nanvuranlat, Physician's Best ChoiceAdvanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)Phase 3NCT07265674
Oct 2027Kallyope Inc.ElismetrepMigrainePhase 3NCT07816367
Oct 2027Loxo Oncology, Inc.Pirtobrutinib, IbrutinibChronic Lymphocytic Leukemia, Leukemia, Lymphocytic and 2 morePhase 3NCT05254743
Oct 2027Neurocrine BiosciencesNBI-1117568SchizophreniaPhase 3NCT06963034
Oct 2027Argenx SEefgartigimod PH20 SCPrimary Immune ThrombocytopeniaPhase 3NCT04812925
Oct 1, 2027Daiichi SankyoTrastuzumab DeruxtecanBreast CancerPhase 3NCT05950945
Oct 1, 2027Roche HoldingGlofitamab, Polatuzumab vedotin, Rituximab and 3 moreLarge B-Cell LymphomaPhase 3NCT06047080
Oct 1, 2027MicroPort NeuroTech Co., Ltd.Experimental Device A, a self-expanding rapamycin target-e…, Experimental Device B, a balloon-expandable rapamycin targ…, Apollo® Intracranial Artery Stent System, a balloon-expand…Intracranial ArteriosclerosisPhase 3NCT06925971
Oct 1, 2027PfizeribuzatrelvirCOVID-19 SARS-CoV-2 InfectionPhase 3NCT06679140
Oct 1, 2027Zhejiang Vimgreen Pharmaceuticals, Ltd.VG081821ACParkinson Disease (PD)Phase 2/3NCT07725562
Oct 2, 2027Boehringer IngelheimTenecteplaseAcute Ischemic StrokePhase 3NCT07361302
Oct 4, 2027AstraZenecaBudesonide/Albuterol metered dose inhaler, MDI, Albuterol sulfate metered dose inhaler, MDIAsthmaPhase 3NCT06471257
Oct 5, 2027UCBrozanolixizumabGeneralized Myasthenia GravisPhase 3NCT06540144
Oct 7, 2027Qilu Pharmaceutical Co., Ltd.QLC7401Primary Hypercholesterolemia or Mixed HyperlipidemiaPhase 3NCT07444086
Oct 7, 2027Argenx SEEmpasiprubart IVChronic Inflammatory Demyelinating Polyneuropathy, CIDP and 1 morePhase 3NCT07091630
Oct 12, 2027PfizerPF-08653944Obesity, Overweight and/or Obesity and 3 morePhase 3NCT07400653
Oct 13, 2027AstraZenecaBDA MDI, AS MDIAsthmaPhase 3NCT06307665
Oct 15, 2027AstraZenecaPuxitatug Samrotecan, Doxorubicin, PaclitaxelEndometrial Cancer, Malignant Solid TumourPhase 3NCT07044336
Oct 15, 2027Servier Affaires MédicalesIvosidenib 500mg Oral Tablet, AzacitidineAcute Myeloid Leukemia (AML)Phase 3NCT05907057
Oct 15, 2027Transdermal Delivery Solutions CorpHuman Insulin, Finger-actuated, Metered Pump SprayerGlucose, High BloodPhase 2/3NCT05159453
Oct 16, 2027ImmunocoreBrenetafusp, Nivolumab, Nivolumab + RelatlimabAdvanced MelanomaPhase 3NCT06112314
Oct 17, 2027Suzhou Abogen Biosciences Co., Ltd.ABO1108Varicella-zoster VirusPhase 3NCT07817108
Oct 18, 2027Merck & Co.MK-8527, Emtricitabine/tenofovir disoproxil (FTC/TDF)Human Immunodeficiency Virus (HIV), HIV Pre-Exposure ProphylaxisPhase 3NCT07071623
Oct 18, 2027NovartisIptacopanParoxysmal Nocturnal HemoglobinuriaPhase 3NCT04747613
Oct 20, 2027Phathom Pharmaceuticals, Inc.VonoprazanSymptomatic Non-erosive Gastroesophageal Reflux DiseasePhase 3NCT07752407
Oct 20, 2027Suzhou Kintor Pharmaceutical Inc,KX-826 0.5% BID, KX-826 1.0% BIDAndrogenetic Alopecia (AGA)Phase 2/3NCT06622824
Oct 20, 2027Throne Biotechnologies Inc.Stem Cell Educator therapyType 1 DiabetesPhase 3NCT04011020

86 phase 2 readouts too. All 130 phase 2 and 3 readouts in Oct 2027

Earnings dates

Biotech and drug companies here reporting results in the next two months: 624 dates.

Full markets calendar

Earnings dates from Nasdaq. Dates can change; check the company’s own announcement.

Trials: ClinicalTrials.gov, the U.S. National Library of Medicine’s registry, industry-sponsored studies only. Completion dates are the sponsor’s own estimates and often slip. Advisory committees: the FDA advisory committee calendar. A trial’s primary completion is when its main measurement is done; companies usually report top-line results weeks to months later, and not always. FDA decision dates (PDUFA goal dates) are not here: the FDA does not publish them, and companies announce them only in their own press releases.